data_2n8n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n8n _Structure_validation_residue.Date_analyzed 2016-10-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.609 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.4 ' NE ' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.41 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.402 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.616 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.423 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.572 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.442 HG23 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.717 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.717 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.442 ' HA ' HG23 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 51.7 mtp180 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.405 -2.706 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.413 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.415 HD11 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.431 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 119.889 -0.1 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.437 ' O ' ' HE1' ' A' ' 21' ' ' MET . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 18' ' ' PRO . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.512 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.753 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 7' ' ' ILE . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.753 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.433 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.415 -2.211 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 11' ' ' GLY . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 10' ' ' GLU . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 C--O 1.214 -0.781 0 CA-C-O 119.606 -0.235 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.6 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.448 HD13 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.555 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.555 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.707 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.707 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.488 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.537 HD13 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.4 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.418 HG21 ' HE2' ' A' ' 57' ' ' MET . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 52' ' ' LYS . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 39' ' ' LYS . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.442 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.581 HG23 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.443 HD11 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' CD ' HH12 ' A' ' 66' ' ' ARG . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.689 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.436 HH12 ' CD ' ' A' ' 56' ' ' GLU . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.419 ' CZ ' ' HB1' ' A' ' 20' ' ' ALA . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.786 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' OE2' ' A' ' 31' ' ' GLU . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.488 ' OE2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.414 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 . . . . . 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.506 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.43 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 52' ' ' LYS . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 63' ' ' THR . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.645 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.645 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 57' ' ' MET . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.403 -2.808 1 N-CA-C 99.362 -4.31 . . . . 0.0 99.362 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.482 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.529 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' HG23 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.475 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.476 HD11 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.499 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 57' ' ' MET . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.8 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.447 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.447 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.532 ' NH1' HG22 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.532 HG22 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.462 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB2' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.462 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HE ' ' HB2' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' HG21 ' A' ' 32' ' ' ILE . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.571 HD11 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.415 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.4 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . 0.818 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 63' ' ' THR . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.818 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.93 111.02 23.41 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -140.54 167.43 22.17 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.43 0.456 . . . . 0.0 110.384 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -123.06 -6.78 8.37 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.815 0.697 . . . . 0.0 109.245 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 6' ' ' VAL . 4.9 p-10 -86.17 -68.45 0.74 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.798 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 55.8 t -123.42 143.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.407 HD13 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.405 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.494 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.434 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.408 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.553 HD21 ' N ' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -92.77 138.41 31.51 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.553 ' N ' HD21 ' A' ' 43' ' ' ASN . 94.5 m-85 -63.2 26.35 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 ' O ' HG22 ' A' ' 40' ' ' ILE . 18.5 pt -85.61 65.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-O 122.922 1.344 . . . . 0.0 109.988 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.38 150.7 47.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 113.468 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 42.9 mm -104.29 132.59 50.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.094 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.2 tp -116.15 138.68 24.37 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.41 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.609 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.609 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.4 HG21 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.4 ' NE ' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.449 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.41 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -108.88 138.35 45.36 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -67.25 125.46 26.14 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.084 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.415 -2.199 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.329 0.109 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 167.53 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' HZ2' ' CD ' ' A' ' 8' ' ' GLU . 43.2 tttm -147.6 5.25 0.8 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 164.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -94.13 72.83 4.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.56 -56.24 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.093 -174.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.92 141.28 40.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.587 ' CD ' ' HZ2' ' A' ' 3' ' ' LYS . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.422 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.616 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.402 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 47' ' ' ILE . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.616 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.423 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.532 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -107.04 109.01 20.79 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -65.91 91.41 0.14 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.795 0.807 . . . . 0.0 112.041 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.5 119.92 47.15 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.13 126.09 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.796 0.808 . . . . 0.0 112.419 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' HB ' ' CE2' ' A' ' 22' ' ' PHE . 49.8 mm -103.05 132.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp -116.54 140.35 26.56 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 122.759 0.423 . . . . 0.0 111.96 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.507 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.47 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -106.93 105.13 15.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.422 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 37.1 t80 -107.48 132.13 53.55 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.26 1.617 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.511 -0.531 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.7 4.62 0.77 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.709 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -146.15 -167.09 2.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.03 91.13 5.44 Favored 'General case' 0 N--CA 1.433 -1.308 1 N-CA-C 99.208 -4.368 . . . . 0.0 99.208 157.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.293 28.2 m-20 -56.7 109.15 0.58 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 -160.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.65 143.31 36.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.521 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.525 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.572 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.451 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.442 HG23 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.484 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 45' ' ' ILE . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -81.92 164.37 21.58 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -71.17 -3.27 19.2 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.9 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 40' ' ' ILE . 22.0 pt -74.84 71.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.932 0.872 . . . . 0.0 111.81 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -68.22 140.61 56.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.257 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.5 mm -84.11 132.64 31.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -124.82 137.36 29.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.717 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.717 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.442 ' HA ' HG23 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 51.7 mtp180 -125.63 103.44 7.85 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.521 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 69.4 t80 -106.47 139.24 41.26 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.875 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.419 ' HE3' ' CA ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.594 ' H1 ' ' CG ' ' A' ' 5' ' ' ASP . 20.4 mmt . . . . . 0 C--O 1.22 -0.473 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.65 94.62 6.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.7 pttp 176.11 -174.53 0.1 Allowed 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.481 1.513 . . . . 0.0 107.049 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -67.11 105.14 1.6 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.594 ' CG ' ' H1 ' ' A' ' 1' ' ' MET . 4.0 t70 -94.05 139.38 31.03 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -161.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t -149.93 144.67 17.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.524 ' OE1' ' HB3' ' A' ' 71' ' ' TYR . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.446 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.413 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.16 178.76 8.09 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.464 ' C ' ' H ' ' A' ' 46' ' ' ARG . 79.9 m-85 -94.94 10.73 34.41 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 pt -82.95 34.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.74 0.781 . . . . 0.0 109.922 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' H ' ' C ' ' A' ' 44' ' ' TYR . 98.5 mtt180 -68.23 144.38 54.92 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 125.607 1.563 . . . . 0.0 111.4 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.62 132.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.867 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -121.88 139.17 29.74 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.446 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.529 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 -120.22 106.02 11.52 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.524 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 71.0 t80 -104.1 148.66 26.0 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.073 -172.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.04 177.62 8.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.14 -175.3 3.81 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -84.01 171.76 12.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.219 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 70.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.367 1.467 . . . . 0.0 113.343 176.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.13 142.29 24.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.415 HD11 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.431 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.523 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.431 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.495 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' HB3' HG12 ' A' ' 45' ' ' ILE . 12.1 t-20 -90.66 -174.54 4.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.41 ' C ' ' H ' ' A' ' 46' ' ' ARG . 96.7 m-85 -98.79 6.26 47.0 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.979 -0.45 . . . . 0.0 111.521 -177.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 43' ' ' ASN . 28.9 pt -77.19 38.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.481 0.658 . . . . 0.0 111.324 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' H ' ' C ' ' A' ' 44' ' ' TYR . 49.3 mtm-85 -80.51 149.55 29.98 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.151 -174.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.498 ' CG2' HG13 ' A' ' 13' ' ' VAL . 2.1 mp -83.22 133.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 125.913 1.685 . . . . 0.0 111.605 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.5 140.94 27.26 Favored Pre-proline 0 C--N 1.312 -1.033 0 C-N-CA 124.278 1.031 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.749 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.749 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.431 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.479 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -107.46 138.12 44.24 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -96.33 148.18 23.02 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.963 0.411 . . . . 0.0 110.375 -171.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.631 ' H ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.261 1.696 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.636 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.92 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.581 ' HE3' ' OE2' ' A' ' 8' ' ' GLU . 21.2 pttp -156.81 159.99 38.78 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -99.5 -5.12 29.82 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.486 ' CG ' ' H ' ' A' ' 6' ' ' VAL . 3.2 p-10 -73.34 -76.91 0.11 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.557 0.694 . . . . 0.0 109.637 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.486 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 6.1 t -113.37 143.26 23.42 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.581 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.541 HG12 ' CG2' ' A' ' 47' ' ' ILE . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.437 ' O ' ' HE1' ' A' ' 21' ' ' MET . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.437 ' HE1' ' O ' ' A' ' 18' ' ' PRO . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.472 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.512 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.414 ' CG2' ' HA ' ' A' ' 46' ' ' ARG . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -83.94 175.52 9.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.432 ' C ' ' H ' ' A' ' 46' ' ' ARG . 80.2 m-85 -96.89 15.84 21.05 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.9 pt -83.25 38.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.158 0.98 . . . . 0.0 109.264 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.432 ' H ' ' C ' ' A' ' 44' ' ' TYR . 98.7 mtt180 -68.51 151.86 46.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.333 1.853 . . . . 0.0 113.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CG2' HG12 ' A' ' 13' ' ' VAL . 47.6 mm -81.86 133.56 28.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.044 -168.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp -123.38 138.0 29.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.433 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.753 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' HG3' ' CD1' ' A' ' 7' ' ' ILE . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.753 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.512 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 -130.62 138.56 50.16 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -91.84 148.02 22.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.703 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.882 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.219 -0.51 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.38 -34.36 12.8 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -136.55 -163.82 1.47 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -91.2 83.2 5.5 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 116.212 -2.195 . . . . 0.0 107.756 166.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.42 -30.02 47.42 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.414 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.3 159.02 40.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 11' ' ' GLY . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' N ' ' HG3' ' A' ' 10' ' ' GLU . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.455 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -119.65 -176.89 3.26 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 8.4 p90 -50.23 -37.73 37.0 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 127.529 2.331 . . . . 0.0 114.243 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.56 100.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 123.731 0.644 . . . . 0.0 110.969 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -125.33 150.32 47.27 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.225 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.85 132.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 123.733 0.646 . . . . 0.0 110.887 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.574 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -117.7 139.8 26.79 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.498 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.574 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.6 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.6 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 138.04 49.19 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -100.65 126.1 47.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.473 0.483 . . . . 0.0 110.931 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.195 175.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.03 -14.93 18.43 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.8 1.286 . . . . 0.0 107.838 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.431 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 18.5 ptmt -176.88 -48.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.431 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -144.69 -178.13 5.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.89 -0.94 21.17 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.223 1.487 . . . . 0.0 108.731 173.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t -113.12 143.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.653 -2.067 . . . . 0.0 105.762 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.448 HD13 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.474 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.532 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.474 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.488 HG21 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.414 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 45' ' ' ILE . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.555 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.555 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.07 -13.65 59.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.6 t80 63.04 26.4 15.43 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 110.587 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 HG13 HG12 ' A' ' 40' ' ' ILE . 18.2 pt -76.64 87.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.893 0.854 . . . . 0.0 111.322 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -67.21 134.6 52.01 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.084 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.2 mt -83.97 132.9 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.39 138.69 48.17 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.4 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.601 ' HB2' ' O ' ' A' ' 71' ' ' TYR . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.43 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.707 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.707 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.488 ' HA ' HG21 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -118.78 130.63 55.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.601 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 2.6 t80 -104.19 148.98 25.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.745 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.457 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . . . -159.91 -171.73 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -144.08 -60.65 0.39 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -125.74 -12.74 6.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.809 0.814 . . . . 0.0 110.09 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -78.57 -46.23 19.9 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.514 1.526 . . . . 0.0 108.852 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.526 ' HB ' ' CB ' ' A' ' 2' ' ' ALA . 59.4 t -127.73 145.55 34.86 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.537 HD13 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.4 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.4 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.418 HG21 ' HE2' ' A' ' 57' ' ' MET . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.467 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -115.26 177.9 4.49 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.418 ' C ' ' H ' ' A' ' 46' ' ' ARG . 25.7 p90 -89.33 10.71 21.36 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.4 pt -82.96 40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 122.046 0.927 . . . . 0.0 110.321 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.418 ' H ' ' C ' ' A' ' 44' ' ' TYR . 37.1 ptt180 -67.42 150.62 48.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.687 -1.597 . . . . 0.0 111.625 -175.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.523 ' CG2' HG13 ' A' ' 13' ' ' VAL . 49.6 mm -83.38 133.38 29.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.903 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp -118.91 137.99 25.6 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.477 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.623 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.523 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.523 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.623 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.467 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 -130.29 114.71 15.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 92.1 t80 -106.59 124.93 50.34 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.442 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 mttt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.498 171.271 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.211 -0.963 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.53 -169.58 1.77 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.57 87.24 4.53 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -110.61 7.86 22.57 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.697 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.9 157.61 16.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.832 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.25 142.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.466 ' HB ' HG23 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG23 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CD ' ' HZ3' ' A' ' 52' ' ' LYS . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.46 HG23 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.447 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 39' ' ' LYS . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -98.71 148.49 23.8 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -78.0 83.55 4.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.722 0.772 . . . . 0.0 109.117 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 pp -86.69 165.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.309 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -130.18 113.04 13.98 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -117.37 121.6 67.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp -111.66 138.02 21.4 Favored Pre-proline 0 C--N 1.278 -2.502 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.41 ' HA ' ' NZ ' ' A' ' 72' ' ' LYS . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.496 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.442 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.642 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.581 HG23 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.642 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.447 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.25 127.53 41.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -105.38 148.44 27.1 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 123.897 0.879 . . . . 0.0 109.11 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' NZ ' ' HA ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 117.571 -1.204 . . . . 0.0 108.611 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.502 -0.88 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -127.45 106.34 9.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -140.17 33.78 1.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.227 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 4.7 pt20 -138.7 -85.25 0.26 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.697 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.431 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.6 OUTLIER -76.41 -57.97 3.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.606 0.762 . . . . 0.0 110.733 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.49 155.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.544 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.443 HD11 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.406 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.406 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.427 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 -112.06 115.75 29.41 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.39 91.29 3.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.181 -172.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.2 mm -84.34 115.06 25.76 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.946 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.16 99.91 0.95 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.188 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.23 132.65 31.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp -124.72 133.84 25.12 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' CD ' HH12 ' A' ' 66' ' ' ARG . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.689 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.532 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.689 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.532 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.436 HH12 ' CD ' ' A' ' 56' ' ' GLU . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 -130.46 106.28 8.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -105.11 144.9 31.27 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.649 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.15 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.46 -8.97 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -165.57 174.7 9.6 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -118.49 0.17 11.53 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.28 -44.06 69.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.998 0.904 . . . . 0.0 110.943 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t -135.09 150.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.555 HG11 ' CG2' ' A' ' 47' ' ' ILE . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.456 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.551 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.45 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.45 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.419 ' CZ ' ' HB1' ' A' ' 20' ' ' ALA . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.421 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.37 172.39 10.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.67 20.83 10.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.93 39.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.935 0.874 . . . . 0.0 109.027 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -79.68 147.75 31.85 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.489 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.555 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.51 133.02 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.27 -175.417 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.71 140.61 29.74 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 124.859 1.264 . . . . 0.0 109.966 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.786 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.786 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.501 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 -111.06 135.33 51.73 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -104.13 126.1 50.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 123.536 0.522 . . . . 0.0 110.87 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' H2 ' ' CD ' ' A' ' 8' ' ' GLU . 1.8 mpt? . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.55 67.31 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.94 0.876 . . . . 0.0 109.078 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -125.78 149.49 48.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 169.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -108.95 89.35 2.96 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.683 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.75 -32.44 65.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 143.55 39.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.4 ' CD ' ' H2 ' ' A' ' 1' ' ' MET . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HE2' ' OE2' ' A' ' 31' ' ' GLU . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.488 ' OE2' ' HE2' ' A' ' 23' ' ' LYS . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.414 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 -123.46 91.86 3.57 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -74.14 90.56 2.05 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 pt -82.33 122.99 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.65 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -83.18 114.09 21.1 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -89.95 127.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.09 139.67 21.9 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.521 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . 0.425 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.506 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -132.0 138.25 48.18 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.38 148.1 27.5 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.82 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS 0.397 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.58 123.21 1.26 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.512 ' HD3' ' OD2' ' A' ' 5' ' ' ASP . 42.9 mttp -145.79 170.57 16.27 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.278 1.031 . . . . 0.0 108.763 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -135.14 19.85 3.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 3' ' ' LYS . 4.4 p-10 -136.06 -66.17 0.56 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.428 -171.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 43.2 t -104.91 161.24 4.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.531 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' HG ' ' OD2' ' A' ' 15' ' ' ASP . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.497 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.43 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.458 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 52' ' ' LYS . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.451 HG21 ' HA ' ' A' ' 63' ' ' THR . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.32 172.11 10.7 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -83.41 6.29 20.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.532 0.733 . . . . 0.0 112.098 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 pt -81.78 37.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.332 -0.855 . . . . 0.0 111.142 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.64 150.87 36.36 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.022 1.329 . . . . 0.0 114.414 -170.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.61 133.71 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.668 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp -126.09 139.93 35.66 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.645 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.645 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.451 ' HA ' HG21 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.48 138.99 49.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.17 124.72 31.46 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HZ1' ' CG ' ' A' ' 51' ' ' ASP . 26.7 tptt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.8 mtt . . . . . 0 C--O 1.212 -0.892 0 CA-C-O 120.248 0.07 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.39 -41.5 60.85 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-O 121.511 0.672 . . . . 0.0 110.595 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -128.8 135.48 49.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -97.05 68.8 2.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.279 0.561 . . . . 0.0 111.651 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.78 -29.79 29.37 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.05 144.39 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.459 HD13 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.438 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.438 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.419 HG21 ' HE2' ' A' ' 57' ' ' MET . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HB3' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.434 HG22 HG23 ' A' ' 45' ' ' ILE . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -107.79 169.71 8.43 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -78.85 81.65 5.12 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.578 0.704 . . . . 0.0 109.627 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.434 HG23 HG22 ' A' ' 40' ' ' ILE . 2.7 pp -91.73 157.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.504 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -129.88 98.27 4.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.343 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.35 123.6 69.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 29.3 tp -126.7 138.43 32.51 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.479 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 72' ' ' LYS . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.676 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.401 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.461 ' CD1' ' HB3' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.472 ' NE ' ' HG2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -114.33 104.1 11.73 Favored 'General case' 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -109.13 119.56 39.9 Favored 'General case' 0 N--CA 1.396 -3.175 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.089 170.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.472 ' HG2' ' NE ' ' A' ' 70' ' ' ARG . 20.7 pttm . . . . . 0 C--N 1.273 -2.741 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 165.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.213 -0.852 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.58 -32.95 25.52 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.579 ' NZ ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -157.19 -151.72 0.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.53 -27.09 68.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.189 1.813 . . . . 0.0 109.992 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.579 ' HA ' ' NZ ' ' A' ' 3' ' ' LYS 0.437 15.1 m-20 85.39 19.43 0.11 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.568 2.604 . . . . 0.0 113.504 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.83 171.78 1.61 Allowed 'Isoleucine or valine' 1 C--N 1.222 -4.97 2 CA-C-N 106.457 -4.883 . . . . 0.0 99.362 166.49 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.481 ' OE2' ' HB2' ' A' ' 3' ' ' LYS . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.442 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 45' ' ' ILE . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.482 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.482 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -89.97 0.53 57.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 58.96 20.56 8.29 Favored 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.926 1.291 . . . . 0.0 113.993 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.465 ' O ' HG21 ' A' ' 40' ' ' ILE . 13.8 pt -73.44 145.02 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.03 150.21 50.53 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -168.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.25 132.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.7 tp -94.0 137.74 22.9 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.433 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -130.33 125.15 33.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -104.62 148.08 26.93 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.2 tptt . . . . . 0 C--N 1.285 -2.214 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.32 -179.735 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 CA--C 1.503 -0.864 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -33.68 41.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 5' ' ' ASP . 10.0 mtmp? -128.28 179.22 5.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.527 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -141.2 18.95 2.26 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.726 0.774 . . . . 0.0 110.077 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' A' ' 3' ' ' LYS . 20.7 p-10 -98.46 -44.21 6.59 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.829 1.251 . . . . 0.0 109.182 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.37 166.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.052 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.529 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.529 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.49 HG23 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.512 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.441 HG21 ' O ' ' A' ' 45' ' ' ILE . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.2 -176.51 5.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -87.7 -1.36 57.91 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.11 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 40' ' ' ILE . 26.6 pt -82.91 55.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.227 1.013 . . . . 0.0 109.698 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -83.63 151.45 25.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.233 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.571 ' CG2' HG11 ' A' ' 13' ' ' VAL . 61.5 mt -91.12 132.41 35.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.716 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -122.28 139.98 31.68 Favored Pre-proline 0 C--N 1.314 -0.956 0 C-N-CA 123.753 0.821 . . . . 0.0 110.632 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.436 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.49 ' HA ' HG23 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.475 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -102.8 106.79 17.46 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -77.1 147.75 36.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.04 0 CA-C-O 117.793 -1.098 . . . . 0.0 108.222 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.72 82.44 5.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -162.55 9.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 50.13 81.5 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.361 1.077 . . . . 0.0 110.197 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -85.5 -14.24 46.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.051 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -105.68 147.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.476 HD11 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.499 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.449 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.481 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG23 ' HE2' ' A' ' 57' ' ' MET . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.8 -3.01 58.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 61.44 20.84 11.53 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 113.508 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 40' ' ' ILE . 17.7 pt -83.72 66.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 123.101 1.429 . . . . 0.0 109.711 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -67.18 151.09 48.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.292 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.9 mm -97.45 132.97 40.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.519 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 30.8 tp -109.51 138.77 20.66 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.481 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.447 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.496 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.496 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.447 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.532 ' NH1' HG22 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.532 HG22 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -120.36 143.13 48.57 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -62.53 124.74 21.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.249 1.023 . . . . 0.0 110.366 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.283 -2.307 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.754 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.013 0.435 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.84 -65.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -162.81 -60.91 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -122.83 78.36 1.53 Allowed 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.285 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.54 -15.97 59.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.294 1.045 . . . . 0.0 109.609 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.575 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.407 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.573 HG12 ' CG2' ' A' ' 47' ' ' ILE . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.462 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' HB2' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.462 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' NZ ' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.545 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.427 HG21 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.436 ' HE ' ' HB2' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -88.89 162.78 15.94 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -78.09 8.31 5.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.9 pt -82.59 50.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.392 0.615 . . . . 0.0 111.51 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -68.36 151.26 47.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.976 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.573 ' CG2' HG12 ' A' ' 13' ' ' VAL . 49.6 mm -84.27 132.84 30.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.951 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -115.71 138.33 23.83 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.407 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' HA ' HG21 ' A' ' 32' ' ' ILE . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.402 ' HG2' HG21 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -120.89 138.56 54.03 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -73.93 126.26 30.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.765 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.035 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.654 ' H1 ' ' CG ' ' A' ' 5' ' ' ASP . 1.5 mpt? . . . . . 0 C--O 1.252 1.201 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.39 -76.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.303 1.441 . . . . 0.0 112.108 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.409 ' HB2' ' HZ1' ' A' ' 3' ' ' LYS . 8.6 mtmp? -106.63 -44.13 4.55 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -83.88 64.53 8.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.725 -1.58 . . . . 0.0 113.427 -168.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.654 ' CG ' ' H1 ' ' A' ' 1' ' ' MET . 6.8 m-20 -114.59 -22.17 9.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 166.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.49 144.38 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.571 HD11 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.593 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.415 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.415 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.88 -5.6 59.05 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 57.42 28.41 15.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.504 1.122 . . . . 0.0 112.738 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.3 pt -78.8 84.03 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.544 1.164 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -68.64 129.9 41.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.131 -1.85 . . . . 0.0 111.848 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.15 130.7 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 27.4 tp -98.97 138.52 20.64 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.593 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' CG ' ' HZ1' ' A' ' 72' ' ' LYS . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.458 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . 0.818 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 63' ' ' THR . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.818 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 61' ' ' ASP . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.578 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.448 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.14 138.44 46.51 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -104.5 123.75 48.05 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 120.953 0.406 . . . . 0.0 109.925 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.465 ' HZ1' ' CG ' ' A' ' 51' ' ' ASP . 15.9 tptt . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 116.172 -1.871 . . . . 0.0 107.088 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 57' ' ' MET . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.2 tp . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 48' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' NE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HE ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.426 HD13 ' HB1' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.606 HG23 ' HE ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 63' ' ' THR . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.481 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 67' ' ' ILE . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' CG ' HH21 ' A' ' 70' ' ' ARG . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.724 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.439 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 53' ' ' VAL . 51.7 mtp180 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.405 -2.706 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' A' ' 57' ' ' MET . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD12 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 119.889 -0.1 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.758 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.758 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.415 -2.211 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.48 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 C--O 1.214 -0.781 0 CA-C-O 119.606 -0.235 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 52' ' ' LYS . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD11 HG13 ' A' ' 7' ' ' ILE . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.592 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 67' ' ' ILE . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.564 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.729 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.545 HD12 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 30' ' ' HIS . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 63' ' ' THR . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 32' ' ' ILE . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.659 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD12 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 33' ' ' LEU . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 17' ' ' LEU . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 9' ' ' LEU . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 7' ' ' ILE . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 . . . . . 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 14' ' ' LEU . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG21 ' HE1' ' A' ' 57' ' ' MET . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.659 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.468 HD12 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.47 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 49' ' ' PRO . 29.3 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.678 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.491 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.403 -2.808 1 N-CA-C 99.362 -4.31 . . . . 0.0 99.362 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.492 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 49' ' ' PRO . 33.7 tp . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.59 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.51 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.699 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.487 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD21 ' HE1' ' A' ' 57' ' ' MET . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 63' ' ' THR . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.409 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.8 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' HD12 ' A' ' 48' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.535 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.588 ' HE1' HD21 ' A' ' 26' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.547 ' NH1' HG23 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.547 HG23 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.493 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.596 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 64' ' ' ARG . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.58 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.517 ' HB ' HG22 ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 49' ' ' PRO . 27.4 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . 0.82 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.82 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.93 111.02 23.41 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -140.54 167.43 22.17 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.43 0.456 . . . . 0.0 110.384 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -123.06 -6.78 8.37 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.815 0.697 . . . . 0.0 109.245 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.17 -68.45 0.74 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.798 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.42 143.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 57' ' ' MET . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -92.77 138.41 31.51 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.591 ' N ' HD22 ' A' ' 43' ' ' ASN . 94.5 m-85 -63.2 26.35 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' ILE . 18.5 pt -85.61 65.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-O 122.922 1.344 . . . . 0.0 109.988 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.38 150.7 47.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 113.468 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HG11 ' A' ' 13' ' ' VAL . 42.9 mm -104.29 132.59 50.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.094 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.2 tp -116.15 138.68 24.37 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 48' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' NE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HE ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.426 HD13 ' HB1' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.606 HG23 ' HE ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -108.88 138.35 45.36 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -67.25 125.46 26.14 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.084 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.415 -2.199 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.329 0.109 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 167.53 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -147.6 5.25 0.8 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 164.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -94.13 72.83 4.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.56 -56.24 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.093 -174.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.92 141.28 40.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 47' ' ' ILE . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 63' ' ' THR . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -107.04 109.01 20.79 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -65.91 91.41 0.14 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.795 0.807 . . . . 0.0 112.041 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.5 119.92 47.15 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.13 126.09 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.796 0.808 . . . . 0.0 112.419 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.434 ' HB ' ' CE2' ' A' ' 22' ' ' PHE . 49.8 mm -103.05 132.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp -116.54 140.35 26.56 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 122.759 0.423 . . . . 0.0 111.96 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.481 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -106.93 105.13 15.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 37.1 t80 -107.48 132.13 53.55 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.26 1.617 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.511 -0.531 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.7 4.62 0.77 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.709 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -146.15 -167.09 2.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.03 91.13 5.44 Favored 'General case' 0 N--CA 1.433 -1.308 1 N-CA-C 99.208 -4.368 . . . . 0.0 99.208 157.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.293 28.2 m-20 -56.7 109.15 0.58 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 -160.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.65 143.31 36.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 67' ' ' ILE . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ILE . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -81.92 164.37 21.58 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -71.17 -3.27 19.2 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.9 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 40' ' ' ILE . 22.0 pt -74.84 71.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.932 0.872 . . . . 0.0 111.81 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -68.22 140.61 56.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.257 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.5 mm -84.11 132.64 31.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -124.82 137.36 29.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' CG ' HH21 ' A' ' 70' ' ' ARG . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.724 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.439 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 53' ' ' VAL . 51.7 mtp180 -125.63 103.44 7.85 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 69.4 t80 -106.47 139.24 41.26 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.875 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HE3' ' CA ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 C--O 1.22 -0.473 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.65 94.62 6.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.7 pttp 176.11 -174.53 0.1 Allowed 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.481 1.513 . . . . 0.0 107.049 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -67.11 105.14 1.6 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -94.05 139.38 31.03 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t -149.93 144.67 17.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE1' ' HB3' ' A' ' 71' ' ' TYR . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.16 178.76 8.09 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 46' ' ' ARG . 79.9 m-85 -94.94 10.73 34.41 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 pt -82.95 34.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.74 0.781 . . . . 0.0 109.922 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' TYR . 98.5 mtt180 -68.23 144.38 54.92 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 125.607 1.563 . . . . 0.0 111.4 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.62 132.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.867 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -121.88 139.17 29.74 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' A' ' 57' ' ' MET . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 -120.22 106.02 11.52 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 71.0 t80 -104.1 148.66 26.0 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.073 -172.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.04 177.62 8.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.14 -175.3 3.81 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -84.01 171.76 12.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.219 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 70.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.367 1.467 . . . . 0.0 113.343 176.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.13 142.29 24.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD12 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' HG12 ' A' ' 45' ' ' ILE . 12.1 t-20 -90.66 -174.54 4.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.79 6.26 47.0 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.979 -0.45 . . . . 0.0 111.521 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 43' ' ' ASN . 28.9 pt -77.19 38.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.481 0.658 . . . . 0.0 111.324 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -80.51 149.55 29.98 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.151 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.1 mp -83.22 133.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 125.913 1.685 . . . . 0.0 111.605 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.5 140.94 27.26 Favored Pre-proline 0 C--N 1.312 -1.033 0 C-N-CA 124.278 1.031 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.758 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.758 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -107.46 138.12 44.24 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -96.33 148.18 23.02 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.963 0.411 . . . . 0.0 110.375 -171.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.788 ' H ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.261 1.696 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.636 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.92 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HE3' ' OE2' ' A' ' 8' ' ' GLU . 21.2 pttp -156.81 159.99 38.78 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -99.5 -5.12 29.82 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 6' ' ' VAL . 3.2 p-10 -73.34 -76.91 0.11 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.557 0.694 . . . . 0.0 109.637 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 6.1 t -113.37 143.26 23.42 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.59 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CG2' ' HA ' ' A' ' 46' ' ' ARG . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -83.94 175.52 9.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 46' ' ' ARG . 80.2 m-85 -96.89 15.84 21.05 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.9 pt -83.25 38.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.158 0.98 . . . . 0.0 109.264 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' CG2' ' A' ' 40' ' ' ILE . 98.7 mtt180 -68.51 151.86 46.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.333 1.853 . . . . 0.0 113.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.551 ' CG2' HG11 ' A' ' 13' ' ' VAL . 47.6 mm -81.86 133.56 28.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.044 -168.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp -123.38 138.0 29.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 -130.62 138.56 50.16 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -91.84 148.02 22.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.729 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.882 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.219 -0.51 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.38 -34.36 12.8 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -136.55 -163.82 1.47 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.459 ' HB3' HD13 ' A' ' 7' ' ' ILE . 13.3 mt-30 -91.2 83.2 5.5 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 116.212 -2.195 . . . . 0.0 107.756 166.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.42 -30.02 47.42 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.414 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.3 159.02 40.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.459 HD13 ' HB3' ' A' ' 4' ' ' GLN . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.48 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 10.8 m120 -119.65 -176.89 3.26 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 8.4 p90 -50.23 -37.73 37.0 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 127.529 2.331 . . . . 0.0 114.243 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.56 100.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 123.731 0.644 . . . . 0.0 110.969 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -125.33 150.32 47.27 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.225 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.85 132.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 123.733 0.646 . . . . 0.0 110.887 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -117.7 139.8 26.79 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 52' ' ' LYS . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD11 HG13 ' A' ' 7' ' ' ILE . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 138.04 49.19 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -100.65 126.1 47.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.473 0.483 . . . . 0.0 110.931 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.195 175.7 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.03 -14.93 18.43 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.8 1.286 . . . . 0.0 107.838 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 18.5 ptmt -176.88 -48.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -144.69 -178.13 5.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.89 -0.94 21.17 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.223 1.487 . . . . 0.0 108.731 173.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 57.7 t -113.12 143.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.653 -2.067 . . . . 0.0 105.762 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.592 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 67' ' ' ILE . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 45' ' ' ILE . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.564 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.07 -13.65 59.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.6 t80 63.04 26.4 15.43 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 110.587 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 40' ' ' ILE . 18.2 pt -76.64 87.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.893 0.854 . . . . 0.0 111.322 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -67.21 134.6 52.01 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.084 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 53' ' ' VAL . 47.2 mt -83.97 132.9 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.39 138.69 48.17 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 71' ' ' TYR . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 47' ' ' ILE . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.729 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -118.78 130.63 55.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.611 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 2.6 t80 -104.19 148.98 25.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.777 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.457 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . . . -159.91 -171.73 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -144.08 -60.65 0.39 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -125.74 -12.74 6.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.809 0.814 . . . . 0.0 110.09 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -78.57 -46.23 19.9 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.514 1.526 . . . . 0.0 108.852 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' CB ' ' A' ' 2' ' ' ALA . 59.4 t -127.73 145.55 34.86 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD12 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 30' ' ' HIS . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 63' ' ' THR . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 47' ' ' ILE . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.412 ' HB3' HG12 ' A' ' 45' ' ' ILE . 19.1 t-20 -115.26 177.9 4.49 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -89.33 10.71 21.36 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 43' ' ' ASN . 33.4 pt -82.96 40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 122.046 0.927 . . . . 0.0 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -67.42 150.62 48.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.687 -1.597 . . . . 0.0 111.625 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CG2' HG11 ' A' ' 13' ' ' VAL . 49.6 mm -83.38 133.38 29.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.903 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp -118.91 137.99 25.6 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 32' ' ' ILE . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 -130.29 114.71 15.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 92.1 t80 -106.59 124.93 50.34 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.442 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HE3' ' H ' ' A' ' 52' ' ' LYS . 77.9 mttt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.498 171.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.211 -0.963 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.53 -169.58 1.77 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.57 87.24 4.53 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -110.61 7.86 22.57 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.697 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.9 157.61 16.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.832 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.25 142.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG23 HG21 ' A' ' 45' ' ' ILE . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -98.71 148.49 23.8 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -78.0 83.55 4.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.722 0.772 . . . . 0.0 109.117 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.564 HG21 HG23 ' A' ' 40' ' ' ILE . 2.1 pp -86.69 165.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.309 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -130.18 113.04 13.98 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -117.37 121.6 67.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp -111.66 138.02 21.4 Favored Pre-proline 0 C--N 1.278 -2.502 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 72' ' ' LYS . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.659 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.25 127.53 41.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -105.38 148.44 27.1 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 123.897 0.879 . . . . 0.0 109.11 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 117.571 -1.204 . . . . 0.0 108.611 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.502 -0.88 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -127.45 106.34 9.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -140.17 33.78 1.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.227 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 4.7 pt20 -138.7 -85.25 0.26 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.697 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.6 OUTLIER -76.41 -57.97 3.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.606 0.762 . . . . 0.0 110.733 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.49 155.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD12 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 -112.06 115.75 29.41 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.39 91.29 3.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.181 -172.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 40' ' ' ILE . 15.2 mm -84.34 115.06 25.76 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.946 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.16 99.91 0.95 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.188 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.23 132.65 31.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp -124.72 133.84 25.12 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 -130.46 106.28 8.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -105.11 144.9 31.27 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.649 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.15 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.46 -8.97 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -165.57 174.7 9.6 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -118.49 0.17 11.53 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.28 -44.06 69.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.998 0.904 . . . . 0.0 110.943 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t -135.09 150.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 33' ' ' LEU . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 17' ' ' LEU . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.37 172.39 10.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.67 20.83 10.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.93 39.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.935 0.874 . . . . 0.0 109.027 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -79.68 147.75 31.85 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.489 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.51 133.02 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.27 -175.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.71 140.61 29.74 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 124.859 1.264 . . . . 0.0 109.966 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 -111.06 135.33 51.73 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -104.13 126.1 50.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 123.536 0.522 . . . . 0.0 110.87 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' H2 ' ' HG2' ' A' ' 4' ' ' GLN . 1.8 mpt? . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.55 67.31 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.94 0.876 . . . . 0.0 109.078 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -125.78 149.49 48.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 169.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' H2 ' ' A' ' 1' ' ' MET . 41.8 mt-30 -108.95 89.35 2.96 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.683 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.75 -32.44 65.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 143.55 39.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 9' ' ' LEU . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 7' ' ' ILE . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 -123.46 91.86 3.57 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -74.14 90.56 2.05 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 pt -82.33 122.99 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.65 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -83.18 114.09 21.1 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -89.95 127.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.09 139.67 21.9 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -132.0 138.25 48.18 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.38 148.1 27.5 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS 0.397 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.58 123.21 1.26 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 5' ' ' ASP . 42.9 mttp -145.79 170.57 16.27 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.278 1.031 . . . . 0.0 108.763 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -135.14 19.85 3.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 3' ' ' LYS . 4.4 p-10 -136.06 -66.17 0.56 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.428 -171.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.91 161.24 4.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 14' ' ' LEU . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 14' ' ' LEU . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG21 ' HE1' ' A' ' 57' ' ' MET . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 47' ' ' ILE . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.32 172.11 10.7 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -83.41 6.29 20.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.532 0.733 . . . . 0.0 112.098 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 pt -81.78 37.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.332 -0.855 . . . . 0.0 111.142 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.64 150.87 36.36 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.022 1.329 . . . . 0.0 114.414 -170.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.61 133.71 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.668 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp -126.09 139.93 35.66 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.659 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.459 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -131.48 138.99 49.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.17 124.72 31.46 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.7 tptt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -176.499 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' OE2' ' A' ' 8' ' ' GLU . 67.8 mtt . . . . . 0 C--O 1.212 -0.892 0 CA-C-O 120.248 0.07 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.39 -41.5 60.85 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-O 121.511 0.672 . . . . 0.0 110.595 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -128.8 135.48 49.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -97.05 68.8 2.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.279 0.561 . . . . 0.0 111.651 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.78 -29.79 29.37 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.05 144.39 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' OE2' ' HG3' ' A' ' 1' ' ' MET . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.468 HD12 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.47 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 45' ' ' ILE . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -107.79 169.71 8.43 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -78.85 81.65 5.12 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.578 0.704 . . . . 0.0 109.627 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.529 HG21 HG23 ' A' ' 40' ' ' ILE . 2.7 pp -91.73 157.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.504 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -129.88 98.27 4.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.343 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.35 123.6 69.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 49' ' ' PRO . 29.3 tp -126.7 138.43 32.51 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.678 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.491 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.546 HH21 ' H ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -114.33 104.1 11.73 Favored 'General case' 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -109.13 119.56 39.9 Favored 'General case' 0 N--CA 1.396 -3.175 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.089 170.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.546 ' H ' HH21 ' A' ' 70' ' ' ARG . 20.7 pttm . . . . . 0 C--N 1.273 -2.741 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 165.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.213 -0.852 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.58 -32.95 25.52 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.578 ' NZ ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -157.19 -151.72 0.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.53 -27.09 68.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.189 1.813 . . . . 0.0 109.992 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.578 ' HA ' ' NZ ' ' A' ' 3' ' ' LYS 0.437 15.1 m-20 85.39 19.43 0.11 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.568 2.604 . . . . 0.0 113.504 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.83 171.78 1.61 Allowed 'Isoleucine or valine' 1 C--N 1.222 -4.97 2 CA-C-N 106.457 -4.883 . . . . 0.0 99.362 166.49 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 3' ' ' LYS . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 45' ' ' ILE . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.492 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -89.97 0.53 57.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 58.96 20.56 8.29 Favored 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.926 1.291 . . . . 0.0 113.993 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 40' ' ' ILE . 13.8 pt -73.44 145.02 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.03 150.21 50.53 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -168.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.25 132.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 49' ' ' PRO . 33.7 tp -94.0 137.74 22.9 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -130.33 125.15 33.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -104.62 148.08 26.93 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 51.2 tptt . . . . . 0 C--N 1.285 -2.214 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.32 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 CA--C 1.503 -0.864 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -33.68 41.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HB3' ' OD1' ' A' ' 5' ' ' ASP . 10.0 mtmp? -128.28 179.22 5.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.527 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -141.2 18.95 2.26 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.726 0.774 . . . . 0.0 110.077 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 3' ' ' LYS . 20.7 p-10 -98.46 -44.21 6.59 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.829 1.251 . . . . 0.0 109.182 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.37 166.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.052 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.59 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.51 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 45' ' ' ILE . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.2 -176.51 5.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -87.7 -1.36 57.91 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.11 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 40' ' ' ILE . 26.6 pt -82.91 55.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.227 1.013 . . . . 0.0 109.698 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -83.63 151.45 25.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.233 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.599 ' CG2' HG11 ' A' ' 13' ' ' VAL . 61.5 mt -91.12 132.41 35.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.716 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -122.28 139.98 31.68 Favored Pre-proline 0 C--N 1.314 -0.956 0 C-N-CA 123.753 0.821 . . . . 0.0 110.632 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.699 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 47' ' ' ILE . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -102.8 106.79 17.46 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -77.1 147.75 36.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.04 0 CA-C-O 117.793 -1.098 . . . . 0.0 108.222 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.72 82.44 5.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -162.55 9.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 50.13 81.5 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.361 1.077 . . . . 0.0 110.197 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -85.5 -14.24 46.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.051 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -105.68 147.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.487 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD21 ' HE1' ' A' ' 57' ' ' MET . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 63' ' ' THR . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.8 -3.01 58.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 61.44 20.84 11.53 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 113.508 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 40' ' ' ILE . 17.7 pt -83.72 66.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 123.101 1.429 . . . . 0.0 109.711 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -67.18 151.09 48.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.292 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG22 HG11 ' A' ' 13' ' ' VAL . 27.9 mm -97.45 132.97 40.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.519 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.8 tp -109.51 138.77 20.66 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' HD12 ' A' ' 48' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.535 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.588 ' HE1' HD21 ' A' ' 26' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.547 ' NH1' HG23 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.547 HG23 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -120.36 143.13 48.57 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -62.53 124.74 21.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.249 1.023 . . . . 0.0 110.366 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.544 ' NZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.283 -2.307 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.754 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.013 0.435 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.84 -65.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 46.4 mtmt -162.81 -60.91 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -122.83 78.36 1.53 Allowed 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.285 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.54 -15.97 59.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.294 1.045 . . . . 0.0 109.609 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.493 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.596 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG21 HG12 ' A' ' 47' ' ' ILE . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -88.89 162.78 15.94 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -78.09 8.31 5.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.9 pt -82.59 50.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.392 0.615 . . . . 0.0 111.51 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -68.36 151.26 47.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.976 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.586 ' CG2' HG11 ' A' ' 13' ' ' VAL . 49.6 mm -84.27 132.84 30.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.951 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -115.71 138.33 23.83 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 64' ' ' ARG . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -120.89 138.56 54.03 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -73.93 126.26 30.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.765 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.035 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.252 1.201 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.39 -76.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.303 1.441 . . . . 0.0 112.108 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 3' ' ' LYS . 8.6 mtmp? -106.63 -44.13 4.55 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -83.88 64.53 8.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.725 -1.58 . . . . 0.0 113.427 -168.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.59 -22.17 9.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.49 144.38 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.58 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.517 ' HB ' HG22 ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.88 -5.6 59.05 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 85.5 m-85 57.42 28.41 15.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.504 1.122 . . . . 0.0 112.738 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.3 pt -78.8 84.03 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.544 1.164 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 97.4 mtt180 -68.64 129.9 41.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.131 -1.85 . . . . 0.0 111.848 -173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.15 130.7 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 49' ' ' PRO . 27.4 tp -98.97 138.52 20.64 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . 0.82 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.82 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -110.14 138.44 46.51 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -104.5 123.75 48.05 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 120.953 0.406 . . . . 0.0 109.925 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 15.9 tptt . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 116.172 -1.871 . . . . 0.0 107.088 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t . . . . . 0 N--CA 1.428 -1.543 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 57' ' ' MET . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.2 tp . . . . . 0 N--CA 1.437 -1.105 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 48' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.409 ' NE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HE ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.426 HD13 ' HB1' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.606 HG23 ' HE ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 . . . . . 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t . . . . . 0 C--O 1.24 0.595 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.624 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 63' ' ' THR . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 . . . . . 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp . . . . . 0 N--CA 1.435 -1.203 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.481 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t . . . . . 0 N--CA 1.419 -1.983 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 67' ' ' ILE . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 . . . . . 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' CG ' HH21 ' A' ' 70' ' ' ARG . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.724 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.439 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 53' ' ' VAL . 51.7 mtp180 . . . . . 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t . . . . . 0 N--CA 1.405 -2.706 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.522 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 . . . . . 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 119.652 -0.213 . . . . 0.0 110.45 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' A' ' 57' ' ' MET . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 . . . . . 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.423 HD12 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 . . . . . 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp . . . . . 0 N--CA 1.446 -0.64 0 CA-C-O 119.889 -0.1 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.758 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.758 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 . . . . . 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.1 t . . . . . 0 N--CA 1.42 -1.964 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp . . . . . 0 N--CA 1.434 -1.266 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.447 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.415 -2.211 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 HG13 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.48 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.8 m120 . . . . . 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 C--O 1.214 -0.781 0 CA-C-O 119.606 -0.235 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 52' ' ' LYS . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.407 HD11 HG13 ' A' ' 7' ' ' ILE . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.7 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.592 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 67' ' ' ILE . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.564 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.43 -1.441 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 11' ' ' GLY . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.729 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.4 t . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.545 HD12 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 30' ' ' HIS . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 63' ' ' THR . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp . . . . . 0 N--CA 1.435 -1.211 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 32' ' ' ILE . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 . . . . . 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t . . . . . 0 N--CA 1.437 -1.093 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp . . . . . 0 N--CA 1.423 -1.784 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.659 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.449 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER . . . . . 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t . . . . . 0 N--CA 1.436 -1.13 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.45 HD12 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 . . . . . 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp . . . . . 0 N--CA 1.428 -1.558 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.705 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 . . . . . 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t . . . . . 0 N--CA 1.433 -1.283 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 33' ' ' LEU . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 17' ' ' LEU . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 . . . . . 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp . . . . . 0 N--CA 1.441 -0.914 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 . . . . . 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.423 -1.781 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 9' ' ' LEU . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 7' ' ' ILE . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.428 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 . . . . . 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.512 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 N--CA 1.441 -0.903 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.498 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.603 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 14' ' ' LEU . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.464 HG21 ' HE1' ' A' ' 57' ' ' MET . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 . . . . . 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp . . . . . 0 N--CA 1.433 -1.304 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.659 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t . . . . . 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.468 HD12 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.47 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.46 ' CD ' ' H ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 . . . . . 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 49' ' ' PRO . 29.3 tp . . . . . 0 N--CA 1.427 -1.603 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.678 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.491 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.403 -2.808 1 N-CA-C 99.362 -4.31 . . . . 0.0 99.362 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.492 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 . . . . . 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 49' ' ' PRO . 33.7 tp . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.59 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.51 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp . . . . . 0 N--CA 1.451 -0.405 0 CA-C-O 119.687 -0.197 . . . . 0.0 110.632 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.699 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.584 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.487 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD21 ' HE1' ' A' ' 57' ' ' MET . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 63' ' ' THR . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.409 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.8 tp . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' HD12 ' A' ' 48' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.535 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.588 ' HE1' HD21 ' A' ' 26' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.547 ' NH1' HG23 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.547 HG23 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 . . . . . 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t . . . . . 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.493 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.596 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.596 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 . . . . . 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp . . . . . 0 N--CA 1.431 -1.394 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 64' ' ' ARG . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 . . . . . 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t . . . . . 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.58 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.517 ' HB ' HG22 ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 . . . . . 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 49' ' ' PRO . 27.4 tp . . . . . 0 N--CA 1.441 -0.913 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . 0.82 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.82 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.93 111.02 23.41 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -140.54 167.43 22.17 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 123.43 0.456 . . . . 0.0 110.384 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -123.06 -6.78 8.37 Favored 'General case' 0 C--N 1.314 -0.97 0 O-C-N 123.815 0.697 . . . . 0.0 109.245 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -86.17 -68.45 0.74 Allowed 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.798 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.42 143.33 36.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 44.9 mt -104.15 126.36 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 177.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -102.45 115.3 30.3 Favored 'General case' 0 C--N 1.291 -1.962 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD12 ' SD ' ' A' ' 57' ' ' MET . 80.8 mt -131.36 161.52 32.19 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -115.83 166.65 11.72 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.985 -0.686 . . . . 0.0 109.576 172.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -159.89 171.39 36.22 Favored Glycine 0 N--CA 1.409 -3.115 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -115.36 127.53 55.46 Favored 'General case' 0 C--N 1.281 -2.392 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.644 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.9 p -88.03 130.7 37.22 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.193 -177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 85.8 mt -104.88 -35.31 7.75 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.894 -179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.19 152.25 49.83 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 120.014 -0.675 . . . . 0.0 110.544 -172.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 16.5 p -100.22 127.13 46.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 47.2 mt -109.9 150.88 41.98 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.31 153.12 40.08 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.025 1.817 . . . . 0.0 112.991 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 t30 73.5 41.27 0.46 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.604 1.162 . . . . 0.0 111.615 174.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.08 11.68 6.01 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.146 0.979 . . . . 0.0 112.711 174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.484 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 1.9 mpp? -89.67 148.96 23.0 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 175.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -140.16 146.75 39.18 Favored 'General case' 0 C--N 1.284 -2.259 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 174.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.8 tttm -98.52 107.97 20.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 176.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.644 HG22 ' HB ' ' A' ' 13' ' ' VAL . 24.5 t -119.27 144.3 28.06 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.661 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.397 -174.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.0 mp0 -109.99 127.64 54.92 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 120.885 0.374 . . . . 0.0 109.996 174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.8 mt -62.47 166.47 5.14 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.344 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -53.85 -27.42 29.78 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.978 0.911 . . . . 0.0 110.32 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.52 -7.2 59.35 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.339 -177.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.4 11.22 62.86 Favored Glycine 0 C--O 1.213 -1.218 0 C-N-CA 119.645 -1.264 . . . . 0.0 112.888 -179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 -88.38 153.96 20.77 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.457 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.02 135.15 35.67 Favored 'General case' 0 C--N 1.267 -2.98 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.565 HG21 ' HE1' ' A' ' 57' ' ' MET . 37.1 pt -139.6 147.61 23.97 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.429 0.633 . . . . 0.0 109.614 177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.3 mt -101.66 123.61 45.94 Favored 'General case' 0 N--CA 1.413 -2.289 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 175.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB1' HD13 ' A' ' 67' ' ' ILE . . . -111.63 158.89 18.73 Favored 'General case' 0 C--N 1.266 -3.039 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.026 -171.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.553 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 80.5 m80 -128.1 133.92 49.07 Favored 'General case' 0 N--CA 1.407 -2.607 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 176.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 21.1 m -83.64 145.78 7.83 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.725 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.156 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 52.3 p -65.79 160.59 22.72 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.62 -24.39 24.59 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 116.166 -0.47 . . . . 0.0 113.468 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -75.79 -29.7 58.84 Favored 'General case' 0 C--O 1.198 -1.632 0 C-N-CA 119.871 -0.731 . . . . 0.0 109.857 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.495 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 86.8 mt -82.48 -21.92 9.43 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.917 0.865 . . . . 0.0 109.543 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.401 ' HE ' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -77.69 -47.15 19.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.317 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.4 mtt -75.57 -45.43 37.82 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.591 HD22 ' N ' ' A' ' 44' ' ' TYR . 0.2 OUTLIER -92.77 138.41 31.51 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 -177.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.591 ' N ' HD22 ' A' ' 43' ' ' ASN . 94.5 m-85 -63.2 26.35 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 ' O ' HG23 ' A' ' 40' ' ' ILE . 18.5 pt -85.61 65.18 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.496 0 CA-C-O 122.922 1.344 . . . . 0.0 109.988 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -68.38 150.7 47.85 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 112.67 -2.059 . . . . 0.0 113.468 -173.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.418 HG22 HG11 ' A' ' 13' ' ' VAL . 42.9 mm -104.29 132.59 50.51 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-N 114.387 -1.278 . . . . 0.0 108.094 178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.2 tp -116.15 138.68 24.37 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.415 ' HD2' HD12 ' A' ' 48' ' ' LEU . 47.6 Cg_exo -46.28 129.0 12.73 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 122.209 1.939 . . . . 0.0 111.129 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.7 -19.44 33.4 Favored Glycine 0 N--CA 1.433 -1.51 0 N-CA-C 111.184 -0.767 . . . . 0.0 111.184 -174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -72.4 148.3 45.36 Favored 'General case' 0 C--O 1.252 1.191 0 CA-C-O 121.711 0.767 . . . . 0.0 112.08 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -103.59 126.29 50.65 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.19 153.93 39.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 69' ' ' TYR . 6.3 m -95.99 117.33 30.43 Favored 'General case' 0 C--O 1.267 1.992 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.199 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.457 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.7 p -110.19 130.3 63.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 4.6 pt-20 -99.67 129.42 45.8 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 176.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.0 ptp -144.66 154.14 42.47 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.0 m -83.26 148.35 55.79 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.151 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.68 -16.15 53.79 Favored 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 123.168 2.579 . . . . 0.0 112.307 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -95.03 3.53 54.78 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.305 -0.862 . . . . 0.0 109.886 -179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -124.26 -84.08 0.65 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.242 -177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.3 tt 63.65 13.76 7.6 Favored 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 125.09 1.356 . . . . 0.0 112.652 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.409 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.5 t -123.34 -17.36 6.59 Favored 'General case' 0 C--N 1.31 -1.126 0 O-C-N 121.227 -0.92 . . . . 0.0 110.523 176.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.409 ' NE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -125.78 139.76 53.25 Favored 'General case' 0 N--CA 1.435 -1.207 0 C-N-CA 124.588 1.155 . . . . 0.0 108.504 174.512 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -145.0 -176.14 18.76 Favored Glycine 0 N--CA 1.43 -1.719 0 C-N-CA 119.502 -1.332 . . . . 0.0 112.768 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.606 ' HE ' HG23 ' A' ' 68' ' ' THR . 0.0 OUTLIER -143.72 128.45 18.25 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.426 HD13 ' HB1' ' A' ' 34' ' ' ALA . 2.2 mp -98.18 125.86 51.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.606 HG23 ' HE ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.21 -23.68 12.18 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.463 -0.79 . . . . 0.0 112.517 173.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.409 ' HD2' ' OG1' ' A' ' 54' ' ' THR . 73.5 t80 -132.6 135.29 45.8 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-O 121.271 0.557 . . . . 0.0 110.771 -176.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -108.88 138.35 45.36 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 106.01 -1.848 . . . . 0.0 106.01 172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -67.25 125.46 26.14 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.475 -0.89 . . . . 0.0 111.084 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.415 -2.199 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 173.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.329 0.109 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 167.53 -78.8 0.0 OUTLIER 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 104.288 -2.486 . . . . 0.0 104.288 176.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.2 tttm -147.6 5.25 0.8 Allowed 'General case' 0 N--CA 1.424 -1.731 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 164.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -94.13 72.83 4.0 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -163.56 -56.24 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 112.688 -2.051 . . . . 0.0 109.093 -174.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.92 141.28 40.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.149 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.8 mt -134.49 140.94 44.78 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -101.65 126.91 48.57 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 76.5 mt -121.71 160.29 24.82 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 178.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.459 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 18.7 mt-10 -133.33 122.1 23.33 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.998 -0.681 . . . . 0.0 111.614 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -136.85 -176.9 14.62 Favored Glycine 0 N--CA 1.42 -2.427 0 C-N-CA 120.353 -0.927 . . . . 0.0 111.567 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.4 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 4.1 m -100.1 132.18 45.62 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.3 p -88.91 127.87 41.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 C-N-CA 119.459 -0.896 . . . . 0.0 111.274 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.1 mp -101.32 -34.66 9.53 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.378 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 1.2 m-20 -128.07 137.39 52.14 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 120.317 -0.553 . . . . 0.0 109.515 -172.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.3 p -101.05 109.33 21.22 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 mt -93.67 151.01 39.68 Favored Pre-proline 0 C--N 1.31 -1.138 0 CA-C-O 121.351 0.596 . . . . 0.0 112.532 -170.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -60.37 154.65 51.6 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 123.359 2.706 . . . . 0.0 111.803 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.39 24.49 1.81 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.869 0.868 . . . . 0.0 112.324 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.87 29.84 10.21 Favored 'General case' 0 C--O 1.248 0.999 0 C-N-CA 124.057 0.943 . . . . 0.0 110.86 177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 32.7 tpp -103.46 159.69 15.36 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 176.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.434 ' CE2' ' HB ' ' A' ' 47' ' ' ILE . 83.9 m-85 -144.17 145.5 32.13 Favored 'General case' 0 C--N 1.266 -3.024 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 27.1 ttpp -103.52 104.59 14.68 Favored 'General case' 0 N--CA 1.424 -1.725 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 177.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 17.1 t -111.04 149.68 13.74 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.522 0 CA-C-N 113.162 -1.836 . . . . 0.0 108.483 -174.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.624 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -105.54 135.73 46.41 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 118.117 0.417 . . . . 0.0 110.643 177.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 75.2 mt -82.91 171.06 14.28 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.934 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -63.35 -17.23 62.37 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.968 1.307 . . . . 0.0 109.761 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.424 ' OD1' ' HB2' ' A' ' 30' ' ' HIS . 21.1 t-20 -78.09 -7.75 57.36 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.798 -1.092 . . . . 0.0 111.232 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.48 9.28 86.0 Favored Glycine 0 C--O 1.224 -0.471 0 CA-C-O 121.982 0.768 . . . . 0.0 111.284 -179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.424 ' HB2' ' OD1' ' A' ' 28' ' ' ASN . 50.9 t-80 -94.89 142.18 27.77 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -95.9 136.22 36.63 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 HG22 ' HA ' ' A' ' 63' ' ' THR . 19.0 pt -127.88 160.41 37.55 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.328 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.817 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 61.3 mt -107.16 124.26 49.45 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.85 151.36 51.74 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 39.5 t-80 -114.5 149.4 36.45 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.3 m -82.97 146.97 6.27 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.053 0 C-N-CA 119.476 -0.89 . . . . 0.0 111.377 176.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 86.4 p -64.88 162.78 15.64 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.945 176.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.36 -14.69 3.44 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 115.7 -0.682 . . . . 0.0 113.645 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.26 -47.99 81.93 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.794 0.797 . . . . 0.0 109.21 178.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 67.2 mt -89.85 -20.39 7.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.518 -175.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.535 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -73.67 -45.4 52.74 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -75.83 -45.26 36.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.331 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -107.04 109.01 20.79 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -65.91 91.41 0.14 Allowed 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.795 0.807 . . . . 0.0 112.041 -176.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.4 mt -98.5 119.92 47.15 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.547 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 175.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.13 126.09 30.3 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 121.796 0.808 . . . . 0.0 112.419 -175.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.434 ' HB ' ' CE2' ' A' ' 22' ' ' PHE . 49.8 mm -103.05 132.33 49.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 172.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.5 mp -116.54 140.35 26.56 Favored Pre-proline 0 C--N 1.296 -1.745 0 C-N-CA 122.759 0.423 . . . . 0.0 111.96 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 90.5 Cg_exo -50.02 125.74 15.41 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.896 1.731 . . . . 0.0 110.043 174.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.96 -11.82 37.8 Favored Glycine 0 N--CA 1.434 -1.438 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.582 -173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.12 152.86 39.79 Favored 'General case' 0 C--O 1.247 0.924 0 CA-C-O 121.364 0.602 . . . . 0.0 111.218 175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -108.11 127.93 54.24 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.07 158.46 43.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.505 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -96.05 120.64 36.7 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 12.6 p -111.13 124.19 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.923 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 66' ' ' ARG . 12.5 pm0 -96.96 130.12 44.32 Favored 'General case' 0 N--CA 1.429 -1.495 0 C-N-CA 119.249 -0.98 . . . . 0.0 108.959 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.501 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 4.8 ptp -151.98 155.14 37.43 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.347 -175.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 63.7 m -91.8 143.77 28.35 Favored Pre-proline 0 C--N 1.29 -2.016 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.616 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -65.15 -13.32 39.14 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 123.443 2.762 . . . . 0.0 112.353 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -80.6 -9.79 59.77 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.857 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -123.09 -71.01 0.74 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.501 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 3.7 tp 59.86 14.18 4.06 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.867 1.667 . . . . 0.0 113.064 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.481 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.8 t -128.02 -8.28 5.44 Favored 'General case' 0 N--CA 1.429 -1.478 0 O-C-N 121.204 -0.935 . . . . 0.0 112.068 177.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.33 138.03 52.2 Favored 'General case' 0 CA--C 1.504 -0.823 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -154.08 -169.3 18.78 Favored Glycine 0 C--N 1.295 -1.706 0 C-N-CA 119.996 -1.097 . . . . 0.0 111.344 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . 34.2 ttm105 -139.46 152.18 46.81 Favored 'General case' 0 N--CA 1.424 -1.766 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.8 mp -97.58 116.22 39.5 Favored 'Isoleucine or valine' 0 C--O 1.264 1.86 0 CA-C-O 121.165 0.507 . . . . 0.0 111.194 176.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.34 -23.04 17.36 Favored 'General case' 0 C--N 1.288 -2.076 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.758 175.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -163.84 160.08 21.86 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -106.93 105.13 15.01 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 174.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.459 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 37.1 t80 -107.48 132.13 53.55 Favored 'General case' 0 C--N 1.276 -2.607 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -172.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.26 1.617 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.511 -0.531 0 CA-C-O 118.837 -0.602 . . . . 0.0 112.583 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.7 4.62 0.77 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 118.984 -1.086 . . . . 0.0 113.709 -175.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 46.8 mttt -146.15 -167.09 2.64 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -80.03 91.13 5.44 Favored 'General case' 0 N--CA 1.433 -1.308 1 N-CA-C 99.208 -4.368 . . . . 0.0 99.208 157.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . 0.293 28.2 m-20 -56.7 109.15 0.58 Allowed 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 117.646 2.461 . . . . 0.0 117.646 -160.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.65 143.31 36.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.072 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.94 137.08 41.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.33 118.63 37.28 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 121.386 0.613 . . . . 0.0 110.197 178.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 73.5 mt -121.88 161.36 22.93 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.559 ' OE2' ' HB3' ' A' ' 71' ' ' TYR . 12.7 mt-10 -125.89 128.06 46.99 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 120.015 -0.674 . . . . 0.0 112.589 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -142.27 177.9 21.24 Favored Glycine 0 N--CA 1.428 -1.889 0 C-N-CA 119.809 -1.186 . . . . 0.0 112.701 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.52 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 5.0 m -102.69 135.4 44.42 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 123.07 0.548 . . . . 0.0 109.85 -177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.3 p -88.81 127.84 41.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.51 -0.744 . . . . 0.0 112.118 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.2 mp -103.25 -37.35 7.72 Favored 'General case' 0 C--O 1.215 -0.726 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.565 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -129.96 150.96 51.01 Favored 'General case' 0 CA--C 1.502 -0.882 0 C-N-CA 120.335 -0.546 . . . . 0.0 111.244 -172.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.5 p -101.05 121.03 41.08 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.123 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.448 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 13.7 mt -107.38 150.52 40.13 Favored Pre-proline 0 C--N 1.316 -0.883 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.35 152.66 65.42 Favored 'Trans proline' 0 CA--C 1.548 1.189 0 C-N-CA 122.512 2.142 . . . . 0.0 112.857 177.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.24 28.11 6.48 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 124.436 1.094 . . . . 0.0 112.167 175.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 26.34 1.95 Allowed 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.752 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.528 ' SD ' ' HD2' ' A' ' 35' ' ' HIS . 4.0 mpp? -90.29 151.07 21.66 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 168.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.86 146.72 36.14 Favored 'General case' 0 C--N 1.278 -2.518 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -96.24 110.31 22.64 Favored 'General case' 0 N--CA 1.424 -1.761 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.582 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 18.6 t -111.56 150.63 13.85 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.957 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.56 -176.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.583 ' O ' ' HA3' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -110.12 136.0 50.04 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 118.893 0.77 . . . . 0.0 110.826 175.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -80.12 167.16 20.73 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.643 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -62.55 -19.48 63.71 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.945 1.298 . . . . 0.0 109.996 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -7.53 56.47 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 115.074 -0.967 . . . . 0.0 109.77 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.68 10.41 79.34 Favored Glycine 0 C--O 1.218 -0.859 0 C-N-CA 120.198 -1.001 . . . . 0.0 111.209 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.449 ' HD2' ' O ' ' A' ' 31' ' ' GLU . 4.2 t60 -94.51 133.8 37.73 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.449 ' O ' ' HD2' ' A' ' 30' ' ' HIS . 11.6 pt-20 -95.94 134.68 38.65 Favored 'General case' 0 C--N 1.274 -2.68 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.609 HG22 ' HA ' ' A' ' 63' ' ' THR . 31.6 pt -125.72 154.62 34.67 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.133 0 CA-C-N 114.704 -1.135 . . . . 0.0 110.295 -170.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 36.6 mt -102.67 124.4 48.13 Favored 'General case' 0 C--N 1.276 -2.608 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.23 158.78 43.48 Favored 'General case' 0 C--N 1.283 -2.316 0 C-N-CA 120.468 -0.493 . . . . 0.0 111.307 -173.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.528 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 37.5 t-80 -118.1 140.13 50.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 67' ' ' ILE . 24.2 m -83.17 146.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.448 175.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 94.3 p -65.32 162.23 17.94 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.124 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.52 -17.45 6.29 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 119.179 -0.789 . . . . 0.0 113.828 177.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -61.07 -48.39 81.94 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 117.8 0.8 . . . . 0.0 109.18 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ILE . 81.6 mt -84.19 -31.05 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.894 -176.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.1 ttt180 -66.87 -46.65 74.35 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.958 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 65.6 mtt -76.4 -45.13 33.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -81.92 164.37 21.58 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -173.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -71.17 -3.27 19.2 Favored 'General case' 0 CA--C 1.548 0.878 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.9 -176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 40' ' ' ILE . 22.0 pt -74.84 71.49 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.932 0.872 . . . . 0.0 111.81 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.7 mmp_? -68.22 140.61 56.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.257 -177.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.5 mm -84.11 132.64 31.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 175.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -124.82 137.36 29.38 Favored Pre-proline 0 C--N 1.297 -1.688 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.58 134.8 33.54 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.622 2.214 . . . . 0.0 111.728 174.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -12.15 41.34 Favored Glycine 0 N--CA 1.436 -1.326 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.461 -177.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' CG ' HH21 ' A' ' 70' ' ' ARG . 15.4 t70 -83.51 157.79 22.24 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -112.26 128.13 56.17 Favored 'General case' 0 C--N 1.274 -2.684 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 70' ' ' ARG . 27.4 m -128.57 157.58 41.09 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.9 m -96.29 115.42 27.41 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.5 p -109.65 129.15 65.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 CA-C-O 121.409 0.623 . . . . 0.0 111.231 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -95.61 125.83 40.47 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 175.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.724 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.4 ptp -140.48 148.87 41.77 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.913 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.3 m -70.51 143.07 89.75 Favored Pre-proline 0 C--N 1.303 -1.432 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.197 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.97 -13.86 37.73 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.962 2.442 . . . . 0.0 112.735 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -102.93 5.1 38.21 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.853 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -116.0 -79.49 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.416 -0.914 . . . . 0.0 111.703 -176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.724 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.8 mp 58.61 16.57 4.39 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.609 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.7 t -128.24 -8.83 5.3 Favored 'General case' 0 N--CA 1.421 -1.881 0 C-N-CA 119.323 -0.951 . . . . 0.0 111.616 174.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -131.28 152.24 50.73 Favored 'General case' 0 C--N 1.318 -0.769 0 C-N-CA 125.848 1.659 . . . . 0.0 107.59 172.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -159.9 -177.96 33.47 Favored Glycine 0 N--CA 1.435 -1.427 0 C-N-CA 119.463 -1.351 . . . . 0.0 112.757 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 16.6 ttm180 -133.42 136.58 45.31 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.439 ' HB ' HG12 ' A' ' 36' ' ' VAL . 2.5 mp -97.3 122.44 48.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 CA-C-O 121.189 0.518 . . . . 0.0 110.929 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -117.27 -10.36 10.79 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.814 178.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -155.94 157.44 36.27 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 -178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.466 ' HG2' HG12 ' A' ' 53' ' ' VAL . 51.7 mtp180 -125.63 103.44 7.85 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.559 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 69.4 t80 -106.47 139.24 41.26 Favored 'General case' 0 C--N 1.288 -2.078 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.875 -178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.424 ' HE3' ' CA ' ' A' ' 72' ' ' LYS . 0.5 OUTLIER . . . . . 0 C--N 1.302 -1.468 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 174.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.4 mmt . . . . . 0 C--O 1.22 -0.473 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -98.65 94.62 6.76 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.7 pttp 176.11 -174.53 0.1 Allowed 'General case' 0 CA--C 1.506 -0.741 0 C-N-CA 125.481 1.513 . . . . 0.0 107.049 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -67.11 105.14 1.6 Allowed 'General case' 0 CA--C 1.501 -0.907 0 N-CA-C 102.751 -3.055 . . . . 0.0 102.751 167.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -94.05 139.38 31.03 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -161.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 89.8 t -149.93 144.67 17.58 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 1 N-CA-C 98.465 -4.643 . . . . 0.0 98.465 178.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.9 mt -103.88 127.33 58.1 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.248 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.706 -173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -101.7 123.18 45.25 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-O 121.834 0.826 . . . . 0.0 111.739 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -125.75 161.36 27.51 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.657 -1.156 . . . . 0.0 107.95 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.548 ' OE1' ' HB3' ' A' ' 71' ' ' TYR . 28.2 mt-10 -116.95 145.8 43.4 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.061 -0.656 . . . . 0.0 110.787 175.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.22 178.38 26.79 Favored Glycine 0 N--CA 1.423 -2.188 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 28.5 m -116.78 133.06 56.47 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 24' ' ' VAL . 0.9 OUTLIER -88.03 130.0 38.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 122.257 -0.277 . . . . 0.0 111.552 179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.3 mp -105.29 -35.84 7.41 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.362 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.522 ' OD1' ' HD3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.98 156.06 43.28 Favored 'General case' 0 C--O 1.247 0.955 0 C-N-CA 120.171 -0.612 . . . . 0.0 111.215 -170.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.6 p -100.04 121.35 41.25 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -109.8 150.32 41.16 Favored Pre-proline 0 C--N 1.307 -1.251 0 C-N-CA 120.259 -0.576 . . . . 0.0 111.476 -175.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.87 153.97 53.31 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.242 2.628 . . . . 0.0 112.406 175.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 74.19 21.38 2.5 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.864 0.866 . . . . 0.0 111.614 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.525 ' HB2' ' HD2' ' A' ' 41' ' ' ARG . . . 68.89 28.61 5.26 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-O 121.672 0.749 . . . . 0.0 110.611 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 35.5 tpp -97.32 161.14 13.94 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 175.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -144.25 149.08 35.75 Favored 'General case' 0 C--N 1.266 -3.061 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD3' ' OD1' ' A' ' 15' ' ' ASP . 61.9 tttt -89.17 113.26 24.42 Favored 'General case' 0 N--CA 1.422 -1.873 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 13' ' ' VAL . 57.9 t -110.44 135.8 48.4 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.88 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 178.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -116.26 119.08 34.6 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 94.7 mt -71.75 166.7 21.45 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.832 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -22.8 66.16 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.495 1.118 . . . . 0.0 111.348 178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -73.36 -7.4 51.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.107 177.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.45 9.97 82.68 Favored Glycine 0 CA--C 1.503 -0.69 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -94.54 132.23 39.44 Favored 'General case' 0 N--CA 1.421 -1.885 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -96.08 142.27 28.47 Favored 'General case' 0 C--N 1.264 -3.116 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 63' ' ' THR . 33.2 pt -133.51 153.6 37.27 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.904 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.4 mt -107.1 124.21 49.35 Favored 'General case' 0 CA--C 1.477 -1.855 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' A' ' 65' ' ' GLY . . . -130.1 143.74 50.96 Favored 'General case' 0 C--N 1.273 -2.727 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.195 -175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.415 ' O ' ' HG3' ' A' ' 66' ' ' ARG . 44.7 t-80 -108.77 141.7 40.4 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -176.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.9 m -83.38 147.9 5.49 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.622 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 83.1 p -65.14 160.47 21.16 Favored 'General case' 0 C--O 1.247 0.962 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.43 -19.98 54.46 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.556 178.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -77.56 -29.06 51.97 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 89.4 mt -88.49 -29.06 5.31 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.815 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.525 ' HD2' ' HB2' ' A' ' 20' ' ' ALA . 6.8 tpm_? -68.56 -49.18 61.4 Favored 'General case' 0 C--O 1.248 0.991 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.934 177.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.7 mmt -76.54 -46.23 27.35 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -176.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -82.16 178.76 8.09 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -174.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.425 ' C ' ' H ' ' A' ' 46' ' ' ARG . 79.9 m-85 -94.94 10.73 34.41 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -174.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 32.1 pt -82.95 34.2 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 121.74 0.781 . . . . 0.0 109.922 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 44' ' ' TYR . 98.5 mtt180 -68.23 144.38 54.92 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 125.607 1.563 . . . . 0.0 111.4 -172.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.7 mm -83.62 132.38 31.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.867 -175.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -121.88 139.17 29.74 Favored Pre-proline 0 C--N 1.306 -1.299 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.45 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -46.9 136.96 16.91 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.648 2.898 . . . . 0.0 112.562 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.64 -21.73 31.81 Favored Glycine 0 N--CA 1.424 -2.112 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.494 -177.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -85.04 158.64 20.4 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.885 0.85 . . . . 0.0 112.003 -177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -101.77 125.87 48.52 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 113.757 -1.565 . . . . 0.0 107.761 -179.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 34.7 m -131.79 158.58 43.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-O 120.861 0.363 . . . . 0.0 111.322 -177.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -99.72 121.82 41.81 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.9 p -111.54 136.72 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.444 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -95.43 131.77 41.21 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.459 ' HB3' ' HE2' ' A' ' 57' ' ' MET . 2.4 mtp -131.18 154.52 48.3 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -78.75 138.8 57.94 Favored Pre-proline 0 C--N 1.285 -2.201 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -177.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.7 -13.44 21.87 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.95 2.433 . . . . 0.0 112.492 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -97.41 -8.5 29.29 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.751 -177.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -123.82 -65.74 1.05 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 118.019 -1.472 . . . . 0.0 114.085 -177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.9 mp 60.3 27.55 17.1 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-O 121.929 0.871 . . . . 0.0 111.646 -175.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.45 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.1 t -127.93 -10.8 5.43 Favored 'General case' 0 N--CA 1.423 -1.792 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.448 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.486 ' HD2' ' N ' ' A' ' 65' ' ' GLY . 2.9 tmm_? -143.87 140.46 29.79 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 -177.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 64' ' ' ARG . . . -152.85 -160.62 9.76 Favored Glycine 0 N--CA 1.44 -1.047 0 C-N-CA 119.216 -1.469 . . . . 0.0 114.178 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' A' ' 35' ' ' HIS . 45.8 ttp180 -141.28 145.48 35.57 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 123.688 0.795 . . . . 0.0 110.355 176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.4 mp -87.16 123.42 39.96 Favored 'Isoleucine or valine' 0 C--O 1.253 1.266 0 O-C-N 123.637 0.585 . . . . 0.0 109.527 175.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.5 p -111.98 -24.24 10.05 Favored 'General case' 0 C--N 1.286 -2.159 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.322 175.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -158.59 160.86 37.05 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -178.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 12.0 ptm180 -120.22 106.02 11.52 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 176.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.548 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 71.0 t80 -104.1 148.66 26.0 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.073 -172.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.538 ' HD2' ' N ' ' A' ' 72' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.292 -1.9 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.1 ttp . . . . . 0 CA--C 1.495 -1.167 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.04 177.62 8.44 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.14 -175.3 3.81 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -84.01 171.76 12.66 Favored 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.219 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 70.46 -70.6 0.15 Allowed 'General case' 0 CA--C 1.503 -0.845 0 C-N-CA 125.367 1.467 . . . . 0.0 113.343 176.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.0 t -112.13 142.29 24.97 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 60.6 mt -114.46 143.53 24.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -177.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -101.76 121.11 41.46 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.677 0.751 . . . . 0.0 110.411 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.423 HD12 ' SD ' ' A' ' 57' ' ' MET . 77.5 mt -121.91 160.98 23.66 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -109.24 156.23 20.16 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 120.644 -0.423 . . . . 0.0 110.907 175.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.21 172.9 37.56 Favored Glycine 0 N--CA 1.425 -2.07 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.8 m -118.93 128.22 54.21 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.52 131.28 36.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 mp -104.67 -35.18 7.9 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.142 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -136.11 158.03 45.39 Favored 'General case' 0 C--O 1.247 0.933 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -173.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.5 p -101.99 120.97 41.27 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 125.113 1.365 . . . . 0.0 110.549 -176.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.45 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 70.3 mt -109.78 149.85 40.51 Favored Pre-proline 0 C--N 1.306 -1.3 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.382 -176.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.74 153.16 38.03 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.147 2.564 . . . . 0.0 112.83 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 74.04 25.22 1.88 Allowed 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.201 1.0 . . . . 0.0 111.477 176.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.31 34.16 6.64 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.792 0.806 . . . . 0.0 110.339 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.45 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 37.5 tpp -103.04 163.1 12.42 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.28 -2.119 . . . . 0.0 105.28 176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -144.14 149.33 36.33 Favored 'General case' 0 C--N 1.269 -2.896 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.3 tttm -92.21 103.93 16.35 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 176.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.591 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.2 t -114.78 132.44 63.96 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.233 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.189 -175.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -101.1 120.19 39.85 Favored 'General case' 0 N--CA 1.416 -2.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.625 176.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.32 162.85 7.18 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.499 176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -53.65 -26.01 20.46 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 124.048 0.939 . . . . 0.0 111.17 179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -92.29 10.61 29.0 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 121.147 0.499 . . . . 0.0 110.729 -176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.89 10.56 83.89 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.428 -0.892 . . . . 0.0 114.479 175.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -94.18 142.0 27.91 Favored 'General case' 0 CA--C 1.484 -1.58 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.89 135.86 37.08 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.416 HG22 ' HA ' ' A' ' 63' ' ' THR . 40.4 pt -132.25 152.76 37.16 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.025 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.759 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 43.0 mt -102.15 123.44 46.0 Favored 'General case' 0 C--N 1.274 -2.694 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 177.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -124.2 138.89 54.36 Favored 'General case' 0 C--N 1.277 -2.562 0 C-N-CA 120.146 -0.621 . . . . 0.0 110.902 -174.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -109.04 136.88 47.82 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.3 m -82.75 147.73 5.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.88 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 177.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.4 p -64.59 160.59 19.3 Favored 'General case' 0 C--O 1.249 1.039 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.363 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.23 -23.37 32.99 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.59 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -71.23 -38.26 71.99 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 117.72 0.76 . . . . 0.0 109.49 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 99.8 mt -78.19 -33.72 18.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 CA-C-N 114.893 -1.049 . . . . 0.0 110.075 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.494 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 0.4 OUTLIER -67.82 -39.15 83.97 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 23.7 mmt -74.64 -45.2 46.39 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.852 0.358 . . . . 0.0 111.829 -178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.433 ' HB3' HG12 ' A' ' 45' ' ' ILE . 12.1 t-20 -90.66 -174.54 4.12 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.307 -173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -98.79 6.26 47.0 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.979 -0.45 . . . . 0.0 111.521 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.433 HG12 ' HB3' ' A' ' 43' ' ' ASN . 28.9 pt -77.19 38.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 CA-C-O 121.481 0.658 . . . . 0.0 111.324 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.3 mtm-85 -80.51 149.55 29.98 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.099 -0.955 . . . . 0.0 112.151 -174.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.1 mp -83.22 133.62 28.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 C-N-CA 125.913 1.685 . . . . 0.0 111.605 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.8 mp -116.5 140.94 27.26 Favored Pre-proline 0 C--N 1.312 -1.033 0 C-N-CA 124.278 1.031 . . . . 0.0 110.914 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -42.18 127.45 4.03 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.899 2.399 . . . . 0.0 111.312 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.19 -18.31 33.61 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.562 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.82 144.89 55.13 Favored 'General case' 0 C--O 1.253 1.263 0 CA-C-O 121.446 0.641 . . . . 0.0 110.62 175.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -104.16 128.74 51.88 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 103.206 -2.887 . . . . 0.0 103.206 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -129.51 157.76 42.18 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.35 115.1 26.89 Favored 'General case' 0 C--O 1.27 2.147 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 174.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.402 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 14.4 p -112.1 127.53 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.217 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.851 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -99.12 127.81 45.14 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-N 116.092 -0.503 . . . . 0.0 109.717 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.758 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.7 ptp -142.66 154.48 44.39 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.001 -176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 m -75.9 144.98 77.05 Favored Pre-proline 0 N--CA 1.428 -1.533 0 CA-C-N 115.015 -0.993 . . . . 0.0 108.856 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.54 -14.92 47.26 Favored 'Trans proline' 0 N--CA 1.488 1.187 0 C-N-CA 122.908 2.405 . . . . 0.0 112.018 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -95.66 1.15 53.41 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.868 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -116.04 -80.2 0.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 119.399 -0.921 . . . . 0.0 111.864 -175.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.758 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.0 mp 58.06 18.22 5.03 Favored 'General case' 0 C--O 1.251 1.174 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.416 ' HA ' HG22 ' A' ' 32' ' ' ILE . 8.4 t -127.63 -15.53 4.97 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-O 121.093 0.473 . . . . 0.0 111.213 175.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.458 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.03 144.81 51.12 Favored 'General case' 0 CA--C 1.502 -0.869 0 C-N-CA 125.431 1.493 . . . . 0.0 107.927 173.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . -150.56 174.02 30.01 Favored Glycine 0 N--CA 1.426 -1.976 0 C-N-CA 119.807 -1.187 . . . . 0.0 112.747 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -128.48 127.19 42.0 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.3 mt -95.76 127.59 47.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.236 0 CA-C-O 122.096 0.95 . . . . 0.0 113.329 -177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -117.41 -23.3 7.82 Favored 'General case' 0 C--N 1.283 -2.317 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.481 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -143.55 144.61 32.02 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.186 -173.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -107.46 138.12 44.24 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -96.33 148.18 23.02 Favored 'General case' 0 C--N 1.278 -2.54 0 CA-C-O 120.963 0.411 . . . . 0.0 110.375 -171.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.788 ' H ' ' HE3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.261 1.696 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.636 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.203 -1.394 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.92 128.4 35.37 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.59 ' HE3' ' OE2' ' A' ' 8' ' ' GLU . 21.2 pttp -156.81 159.99 38.78 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -99.5 -5.12 29.82 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 6' ' ' VAL . 3.2 p-10 -73.34 -76.91 0.11 Allowed 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.557 0.694 . . . . 0.0 109.637 177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' H ' ' CG ' ' A' ' 5' ' ' ASP . 6.1 t -113.37 143.26 23.42 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 N-CA-C 103.251 -2.87 . . . . 0.0 103.251 168.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' CD1' ' HG3' ' A' ' 59' ' ' PRO . 4.6 mp -102.49 131.86 49.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 C-N-CA 119.901 -0.72 . . . . 0.0 110.937 -168.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.59 ' OE2' ' HE3' ' A' ' 3' ' ' LYS . 47.6 mt-10 -102.99 130.73 50.19 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.189 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.0 mt -121.58 163.67 18.53 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 105.877 -1.898 . . . . 0.0 105.877 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -108.56 168.16 9.53 Favored 'General case' 0 C--N 1.263 -3.186 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.982 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 25' ' ' GLU . . . -176.09 165.18 35.57 Favored Glycine 0 N--CA 1.417 -2.627 0 C-N-CA 118.72 -1.705 . . . . 0.0 113.012 173.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.404 ' HB ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 m -100.89 128.9 46.73 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -178.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.4 p -87.08 124.75 40.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 C-N-CA 118.995 -1.082 . . . . 0.0 111.182 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.28 -34.8 8.66 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.193 -175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HE3' ' A' ' 23' ' ' LYS . 14.2 t70 -136.26 157.65 46.3 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-O 121.53 0.681 . . . . 0.0 112.552 -172.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 38.8 p -115.09 126.57 54.83 Favored 'General case' 0 C--N 1.286 -2.152 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.215 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 45.6 mt -106.35 150.2 39.17 Favored Pre-proline 0 N--CA 1.43 -1.446 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.14 152.09 83.42 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 121.751 1.634 . . . . 0.0 113.218 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.464 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 65.7 t30 72.18 28.57 2.42 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.733 1.213 . . . . 0.0 112.84 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 79.67 19.79 0.66 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.011 1.324 . . . . 0.0 113.409 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.466 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 2.6 mpp? -89.61 146.93 24.21 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 170.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -135.29 149.29 49.76 Favored 'General case' 0 C--N 1.283 -2.316 0 O-C-N 121.681 -0.637 . . . . 0.0 109.888 177.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' HE3' ' OD2' ' A' ' 15' ' ' ASP . 26.2 ttpp -110.64 104.53 13.22 Favored 'General case' 0 N--CA 1.415 -2.225 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.552 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 23.2 t -110.57 150.39 13.09 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.695 0 CA-C-N 113.14 -1.845 . . . . 0.0 108.745 -170.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -103.8 134.91 46.31 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 94.1 mt -82.36 157.35 23.78 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 170.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -64.46 -5.82 6.1 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-O 121.744 0.783 . . . . 0.0 112.397 177.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -76.59 -8.18 56.7 Favored 'General case' 0 CA--C 1.555 1.172 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.635 174.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.57 1.42 83.3 Favored Glycine 0 C--O 1.223 -0.581 0 CA-C-O 121.52 0.511 . . . . 0.0 111.977 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 46.9 t-80 -95.1 141.08 29.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 15.8 pt-20 -96.49 146.54 24.7 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.544 HG22 ' HA ' ' A' ' 63' ' ' THR . 23.8 pt -129.63 153.67 39.13 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.544 -172.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.4 mt -102.16 123.97 46.94 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 106.789 -1.56 . . . . 0.0 106.789 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.01 159.09 36.1 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 66.2 m80 -118.41 141.38 48.6 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.766 -1.107 . . . . 0.0 108.226 177.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.401 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 16.1 m -83.96 145.68 7.89 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.118 175.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 98.6 p -66.91 161.4 24.14 Favored 'General case' 0 C--O 1.247 0.972 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.601 177.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.28 -19.1 7.63 Favored Glycine 0 CA--C 1.532 1.115 0 CA-C-O 119.336 -0.702 . . . . 0.0 113.726 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -63.89 -48.39 76.84 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-O 122.172 0.987 . . . . 0.0 108.523 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.41 ' CG2' ' HA ' ' A' ' 46' ' ' ARG . 68.9 mt -90.94 -24.54 5.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-N 113.944 -1.48 . . . . 0.0 110.672 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.31 -47.74 54.81 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.569 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.9 mtt -76.77 -46.76 23.93 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 120.906 0.384 . . . . 0.0 111.96 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -83.94 175.52 9.51 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -173.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' C ' ' H ' ' A' ' 46' ' ' ARG . 80.2 m-85 -96.89 15.84 21.05 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -176.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 30.9 pt -83.25 38.28 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-O 122.158 0.98 . . . . 0.0 109.264 176.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.41 ' HA ' ' CG2' ' A' ' 40' ' ' ILE . 98.7 mtt180 -68.51 151.86 46.2 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 126.333 1.853 . . . . 0.0 113.274 -171.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.551 ' CG2' HG11 ' A' ' 13' ' ' VAL . 47.6 mm -81.86 133.56 28.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.044 -168.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 34.8 tp -123.38 138.0 29.36 Favored Pre-proline 0 C--N 1.306 -1.29 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -49.68 141.41 27.24 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 122.962 2.442 . . . . 0.0 112.828 177.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.73 -17.38 39.09 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.53 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.447 ' CG ' HH21 ' A' ' 70' ' ' ARG . 0.2 OUTLIER -83.39 153.13 24.7 Favored 'General case' 0 C--O 1.246 0.887 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.07 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.8 tttm -112.31 125.78 54.55 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 178.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 m -119.9 162.15 18.61 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 120.842 0.353 . . . . 0.0 111.652 -173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.2 m -97.63 125.99 42.68 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 174.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.8 p -118.9 127.35 75.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 121.185 0.517 . . . . 0.0 110.919 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -94.49 128.84 41.33 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.774 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.7 ptp -143.41 150.81 39.6 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.712 0.768 . . . . 0.0 112.239 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.407 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 0.6 OUTLIER -72.61 145.61 87.53 Favored Pre-proline 0 N--CA 1.404 -2.736 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.178 179.103 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 12.2 Cg_exo -66.9 -13.43 39.9 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 122.752 2.301 . . . . 0.0 112.658 -176.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -90.98 -11.84 37.73 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.997 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -103.36 -85.39 0.45 Allowed 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.774 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 59.19 10.5 1.71 Allowed 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.084 0.953 . . . . 0.0 112.685 -172.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.544 ' HA ' HG22 ' A' ' 32' ' ' ILE . 15.2 t -122.55 -0.5 9.2 Favored 'General case' 0 N--CA 1.418 -2.042 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -155.03 150.04 26.86 Favored 'General case' 0 N--CA 1.418 -2.07 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.06 -162.59 20.35 Favored Glycine 0 CA--C 1.536 1.369 0 C-N-CA 119.674 -1.25 . . . . 0.0 114.001 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 14.5 ttm180 -139.0 136.2 35.1 Favored 'General case' 0 C--O 1.207 -1.136 0 C-N-CA 124.539 1.135 . . . . 0.0 109.483 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.1 mp -77.94 124.55 36.52 Favored 'Isoleucine or valine' 0 C--O 1.251 1.152 0 CA-C-N 118.186 0.448 . . . . 0.0 110.817 178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.7 p -103.94 -24.71 13.23 Favored 'General case' 0 C--O 1.265 1.888 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.912 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 t80 -163.54 159.71 22.26 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 123.614 0.766 . . . . 0.0 109.004 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.447 HH21 ' CG ' ' A' ' 51' ' ' ASP . 16.3 ptm180 -130.62 138.56 50.16 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 176.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -91.84 148.02 22.54 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.729 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.882 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.219 -0.51 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.38 -34.36 12.8 Favored 'General case' 0 C--O 1.219 -0.524 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -136.55 -163.82 1.47 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 102.031 -3.322 . . . . 0.0 102.031 173.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.459 ' HB3' HD13 ' A' ' 7' ' ' ILE . 13.3 mt-30 -91.2 83.2 5.5 Favored 'General case' 0 C--N 1.287 -2.125 0 C-N-CA 116.212 -2.195 . . . . 0.0 107.756 166.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.42 -30.02 47.42 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 112.42 -2.173 . . . . 0.0 107.414 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 58.5 t -135.3 159.02 40.9 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 1 N-CA-C 99.635 -4.209 . . . . 0.0 99.635 173.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.459 HD13 ' HB3' ' A' ' 4' ' ' GLN . 41.1 mm -103.19 117.21 48.26 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.011 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.178 -178.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 23.0 mp0 -101.64 115.83 31.4 Favored 'General case' 0 N--CA 1.418 -2.041 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.3 160.91 39.63 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -113.89 150.2 34.01 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -146.46 177.49 24.76 Favored Glycine 0 N--CA 1.425 -2.058 0 C-N-CA 120.308 -0.948 . . . . 0.0 111.823 177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -125.35 126.84 45.68 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.6 p -89.05 132.55 33.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 7.1 mp -102.87 -39.88 6.78 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.97 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.45 157.06 42.15 Favored 'General case' 0 C--O 1.247 0.941 0 C-N-CA 119.805 -0.758 . . . . 0.0 112.539 -172.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.0 p -100.37 114.27 27.67 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.464 -1.244 . . . . 0.0 107.82 174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.48 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 40.4 mt -102.37 150.28 37.43 Favored Pre-proline 0 C--N 1.302 -1.467 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.443 -176.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.16 151.98 32.79 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.734 2.29 . . . . 0.0 113.008 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 65.6 t30 71.33 21.0 4.79 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 124.477 1.111 . . . . 0.0 111.316 177.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.74 36.81 4.46 Favored 'General case' 0 C--O 1.248 1.025 0 C-N-CA 124.293 1.037 . . . . 0.0 111.034 178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.48 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.8 tpt -98.95 158.04 15.91 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 103.525 -2.769 . . . . 0.0 103.525 174.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -137.86 145.95 42.83 Favored 'General case' 0 C--N 1.257 -3.441 0 O-C-N 121.769 -0.582 . . . . 0.0 110.075 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.21 105.29 17.32 Favored 'General case' 0 N--CA 1.428 -1.547 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.6 t -113.16 132.09 62.99 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.758 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.569 -175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.03 123.95 46.79 Favored 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.0 mt -66.07 159.86 25.12 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.655 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -64.09 -11.09 26.59 Favored 'General case' 0 CA--C 1.561 1.383 0 CA-C-O 122.437 1.113 . . . . 0.0 109.207 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -81.03 -7.82 59.64 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.772 1.629 . . . . 0.0 110.552 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.77 10.94 83.53 Favored Glycine 0 N--CA 1.466 0.68 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.327 -175.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -90.78 138.18 31.79 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 -176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.88 134.9 39.6 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.7 pt -137.95 139.28 42.81 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.557 0 CA-C-O 121.813 0.815 . . . . 0.0 109.727 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.5 mt -101.92 123.71 46.31 Favored 'General case' 0 C--N 1.273 -2.751 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.26 157.29 44.76 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.026 -173.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 32.7 t-80 -116.63 141.88 47.61 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.87 -177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 40' ' ' ILE . 29.5 m -83.65 149.79 4.38 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.874 176.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.6 p -63.5 160.99 15.29 Favored 'General case' 0 C--O 1.247 0.969 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.63 -24.93 41.52 Favored Glycine 0 C--O 1.219 -0.789 0 CA-C-N 115.829 -0.623 . . . . 0.0 113.764 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -79.64 -28.78 40.84 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 117.909 0.854 . . . . 0.0 110.313 -177.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 82.6 mt -78.35 -26.93 14.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.793 0.806 . . . . 0.0 109.827 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -82.01 -48.66 11.17 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 120.061 -0.656 . . . . 0.0 111.035 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.3 mmt -77.42 -18.74 56.99 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 -175.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.407 ' HB3' ' CD1' ' A' ' 44' ' ' TYR . 10.8 m120 -119.65 -176.89 3.26 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' HB3' ' A' ' 43' ' ' ASN . 8.4 p90 -50.23 -37.73 37.0 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 127.529 2.331 . . . . 0.0 114.243 178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.6 pt -80.56 100.24 4.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 O-C-N 123.731 0.644 . . . . 0.0 110.969 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.1 mtm180 -125.33 150.32 47.27 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.225 -176.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.9 mm -91.85 132.61 35.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 123.733 0.646 . . . . 0.0 110.887 -175.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -117.7 139.8 26.79 Favored Pre-proline 0 C--N 1.309 -1.162 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.1 178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 73.8 Cg_exo -44.69 125.93 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.518 2.812 . . . . 0.0 112.448 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.4 -6.41 39.0 Favored Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.591 ' HB2' ' O ' ' A' ' 48' ' ' LEU . 4.1 t0 -76.52 159.19 30.59 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-O 121.441 0.639 . . . . 0.0 110.963 -177.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HD2' ' HA ' ' A' ' 52' ' ' LYS . 27.0 mmmt -109.26 125.28 52.11 Favored 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.983 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -141.12 142.95 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.461 0 CA-C-O 121.593 0.711 . . . . 0.0 111.302 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 7.1 m -95.42 128.99 42.73 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 114.394 -1.276 . . . . 0.0 107.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.25 137.87 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-O 121.752 0.787 . . . . 0.0 111.969 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -101.13 129.83 47.09 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -132.6 156.36 47.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 m -84.36 143.11 41.3 Favored Pre-proline 0 C--N 1.289 -2.042 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -61.05 -13.15 26.08 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 C-N-CA 123.034 2.489 . . . . 0.0 112.621 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -91.67 -10.88 38.67 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.096 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -121.94 -65.49 1.12 Allowed 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 118.878 -1.129 . . . . 0.0 113.425 -176.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.407 HD11 HG13 ' A' ' 7' ' ' ILE . 7.9 mp 56.41 26.9 11.29 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.525 1.13 . . . . 0.0 111.345 -172.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.606 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 10.3 t -128.83 -22.49 3.23 Favored 'General case' 0 N--CA 1.409 -2.523 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.091 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 63' ' ' THR . 2.6 mpt_? -133.09 163.77 28.51 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 124.261 1.024 . . . . 0.0 108.264 -178.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.7 -166.49 35.43 Favored Glycine 0 C--O 1.242 0.634 0 C-N-CA 117.941 -2.075 . . . . 0.0 113.963 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttp180 -131.15 149.11 52.73 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 122.772 0.429 . . . . 0.0 111.043 177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.8 mp -93.58 118.45 39.42 Favored 'Isoleucine or valine' 0 C--O 1.252 1.235 0 CA-C-N 115.421 -0.808 . . . . 0.0 110.73 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.7 p -117.76 -24.19 7.29 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 173.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -128.39 149.73 50.41 Favored 'General case' 0 C--N 1.307 -1.246 0 O-C-N 121.463 -0.773 . . . . 0.0 109.692 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.22 138.04 49.19 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -100.65 126.1 47.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 123.473 0.483 . . . . 0.0 110.931 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt . . . . . 0 C--N 1.305 -1.337 0 CA-C-O 117.387 -1.292 . . . . 0.0 108.195 175.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 110.412 -0.218 . . . . 0.0 110.412 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.03 -14.93 18.43 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.8 1.286 . . . . 0.0 107.838 172.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.464 ' HG3' ' H ' ' A' ' 4' ' ' GLN . 18.5 ptmt -176.88 -48.19 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' H ' ' HG3' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -144.69 -178.13 5.85 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 100.848 -3.76 . . . . 0.0 100.848 167.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -107.89 -0.94 21.17 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-O 123.223 1.487 . . . . 0.0 108.731 173.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 57.7 t -113.12 143.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.961 0 CA-C-N 112.653 -2.067 . . . . 0.0 105.762 175.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.7 mp -110.78 147.5 14.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.71 124.16 47.73 Favored 'General case' 0 N--CA 1.431 -1.388 0 CA-C-O 121.381 0.61 . . . . 0.0 109.608 178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.455 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.7 mt -121.67 162.42 20.76 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.541 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -107.64 143.37 36.2 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' LYS . . . -155.31 165.65 32.41 Favored Glycine 0 CA--C 1.482 -2.0 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 177.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 m -110.21 127.05 54.75 Favored 'General case' 0 C--N 1.285 -2.227 0 C-N-CA 123.104 0.562 . . . . 0.0 109.595 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.625 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -88.37 133.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.569 -178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 66.3 mt -90.68 -43.9 9.83 Favored 'General case' 0 C--O 1.211 -0.968 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.02 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -165.22 161.92 19.61 Favored 'General case' 0 C--O 1.253 1.281 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 80.9 p -99.07 124.02 43.78 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 123.831 0.852 . . . . 0.0 109.573 -173.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.592 ' HB2' ' HB2' ' A' ' 21' ' ' MET . 12.0 mt -94.71 150.66 38.29 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -174.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.65 152.38 6.61 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 122.966 2.444 . . . . 0.0 112.849 175.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 74.26 20.57 2.62 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 124.992 1.317 . . . . 0.0 112.035 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 69.8 33.64 2.84 Favored 'General case' 0 C--O 1.249 1.07 0 C-N-CA 124.555 1.142 . . . . 0.0 111.775 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.592 ' HB2' ' HB2' ' A' ' 17' ' ' LEU . 23.6 mmt -96.95 144.81 26.51 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 174.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -119.39 133.79 55.54 Favored 'General case' 0 C--N 1.257 -3.442 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 176.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -89.41 104.08 16.66 Favored 'General case' 0 CA--C 1.472 -2.033 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.625 HG22 ' HB ' ' A' ' 13' ' ' VAL . 27.3 t -116.64 136.44 53.71 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.912 0 CA-C-N 113.886 -1.506 . . . . 0.0 110.538 -175.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.83 121.77 44.36 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.147 0.498 . . . . 0.0 110.033 174.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 89.6 mt -67.52 166.56 14.56 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.366 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.67 -23.8 67.3 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.11 176.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -73.34 -7.19 50.55 Favored 'General case' 0 C--N 1.315 -0.928 0 C-N-CA 124.983 1.313 . . . . 0.0 111.388 177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.83 11.0 82.28 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 120.07 -1.062 . . . . 0.0 110.978 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -94.4 140.21 30.11 Favored 'General case' 0 N--CA 1.423 -1.806 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -96.22 138.37 33.93 Favored 'General case' 0 C--N 1.272 -2.782 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.502 HG22 ' HA ' ' A' ' 63' ' ' THR . 38.1 pt -134.43 142.73 39.92 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-O 121.898 0.856 . . . . 0.0 109.608 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 76.0 mt -102.15 122.39 44.06 Favored 'General case' 0 N--CA 1.402 -2.842 0 N-CA-C 104.152 -2.536 . . . . 0.0 104.152 172.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.81 158.76 34.17 Favored 'General case' 0 C--N 1.259 -3.33 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -176.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.443 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 49.6 t-80 -116.15 141.01 48.7 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG12 ' HB ' ' A' ' 67' ' ' ILE . 19.2 m -83.06 146.61 6.76 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.02 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.845 177.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.5 p -65.66 162.1 19.15 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.703 175.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.9 -17.24 9.03 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-N 116.177 -0.465 . . . . 0.0 112.633 175.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.82 -43.91 97.56 Favored 'General case' 0 C--O 1.218 -0.575 0 C-N-CA 123.986 0.914 . . . . 0.0 109.707 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 HG13 ' A' ' 45' ' ' ILE . 50.9 mt -90.24 -32.72 5.6 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.018 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.564 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -62.04 -45.02 95.41 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.564 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 16.3 tpt -74.38 -45.05 49.41 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -174.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -78.07 -13.65 59.79 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.6 t80 63.04 26.4 15.43 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.637 1.175 . . . . 0.0 110.587 177.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 40' ' ' ILE . 18.2 pt -76.64 87.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-O 121.893 0.854 . . . . 0.0 111.322 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -67.21 134.6 52.01 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 114.845 -1.07 . . . . 0.0 110.084 -174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.52 HD13 HG12 ' A' ' 53' ' ' VAL . 47.2 mt -83.97 132.9 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -81.39 138.69 48.17 Favored Pre-proline 0 C--N 1.295 -1.786 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -52.52 125.13 16.85 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.665 2.243 . . . . 0.0 110.612 175.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 103.8 -13.86 53.21 Favored Glycine 0 N--CA 1.433 -1.506 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.859 -177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -84.49 159.47 20.73 Favored 'General case' 0 C--O 1.255 1.373 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -178.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 71' ' ' TYR . 99.3 mttt -95.82 148.75 22.27 Favored 'General case' 0 C--N 1.281 -2.381 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.306 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.52 HG12 HD13 ' A' ' 47' ' ' ILE . 16.9 m -122.65 158.04 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 173.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.4 m -101.31 114.77 29.05 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 105.222 -2.14 . . . . 0.0 105.222 171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 66' ' ' ARG . 10.1 p -115.4 124.32 71.81 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 O-C-N 123.653 0.595 . . . . 0.0 110.361 -176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.429 ' CD ' HH21 ' A' ' 66' ' ' ARG . 0.7 OUTLIER -96.76 132.5 42.4 Favored 'General case' 0 N--CA 1.421 -1.923 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.344 175.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.729 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 14.7 ptp -146.88 154.15 40.98 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.536 0.684 . . . . 0.0 112.471 -176.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 p -75.35 146.89 81.94 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.372 -1.286 . . . . 0.0 110.779 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -71.27 -13.17 30.69 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.551 2.168 . . . . 0.0 112.754 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -88.29 -16.71 32.39 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.255 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -105.42 -78.63 0.57 Allowed 'General case' 0 CA--C 1.501 -0.931 0 CA-C-O 121.317 0.579 . . . . 0.0 111.503 -175.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.729 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 6.9 tt 59.25 18.27 6.46 Favored 'General case' 0 CA--C 1.562 1.441 0 CA-C-O 123.031 1.396 . . . . 0.0 109.264 -174.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.502 ' HA ' HG22 ' A' ' 32' ' ' ILE . 13.9 t -127.3 -2.23 6.29 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.459 178.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 32.2 tpt180 -148.44 147.11 28.8 Favored 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -177.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -169.84 -172.64 36.58 Favored Glycine 0 C--O 1.256 1.475 0 N-CA-C 110.864 -0.894 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 51.6 ttp180 -133.02 151.52 52.05 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 178.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' N ' ' HG2' ' A' ' 66' ' ' ARG . 2.8 mp -98.6 122.81 50.7 Favored 'Isoleucine or valine' 0 C--O 1.266 1.931 0 CA-C-O 121.071 0.462 . . . . 0.0 111.674 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.9 p -113.57 -24.02 9.46 Favored 'General case' 0 C--O 1.269 2.13 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.033 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -144.3 171.71 13.94 Favored 'General case' 0 N--CA 1.403 -2.808 0 CA-C-O 121.212 0.529 . . . . 0.0 111.717 -178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 41.5 mtp180 -118.78 130.63 55.89 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.611 ' O ' ' HB2' ' A' ' 52' ' ' LYS . 2.6 t80 -104.19 148.98 25.69 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.309 -0.996 . . . . 0.0 108.309 -172.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.777 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.299 -1.615 0 CA-C-O 117.818 -1.087 . . . . 0.0 111.457 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 ttp . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.539 ' CB ' ' HB ' ' A' ' 6' ' ' VAL . . . -159.91 -171.73 3.36 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' HA ' ' HE3' ' A' ' 3' ' ' LYS . 0.0 OUTLIER -144.08 -60.65 0.39 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 175.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -125.74 -12.74 6.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.809 0.814 . . . . 0.0 110.09 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -78.57 -46.23 19.9 Favored 'General case' 0 C--N 1.292 -1.91 0 C-N-CA 125.514 1.526 . . . . 0.0 108.852 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' HB ' ' CB ' ' A' ' 2' ' ' ALA . 59.4 t -127.73 145.55 34.86 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.68 0 N-CA-C 105.228 -2.138 . . . . 0.0 105.228 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.2 mm -103.9 133.43 47.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -176.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -102.82 116.06 31.82 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.545 HD12 ' SD ' ' A' ' 57' ' ' MET . 69.4 mt -125.89 162.0 26.17 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -120.62 164.97 15.7 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 119.046 -1.061 . . . . 0.0 111.007 177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.65 177.95 38.58 Favored Glycine 0 N--CA 1.419 -2.443 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.136 178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.1 m -115.22 129.29 56.6 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.2 p -88.12 128.65 40.32 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.156 0 CA-C-O 121.06 0.457 . . . . 0.0 111.584 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -105.44 -34.73 7.72 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.949 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -127.13 149.4 49.97 Favored 'General case' 0 C--O 1.246 0.893 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.881 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.3 p -100.08 121.92 42.14 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.021 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 54.4 mt -109.8 150.43 41.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.192 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.42 153.64 73.33 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.705 2.27 . . . . 0.0 112.653 176.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 16.4 m120 73.66 29.6 1.5 Allowed 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 174.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 68.16 31.8 5.15 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.7 0.8 . . . . 0.0 110.796 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.419 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.6 tpt -109.22 156.7 19.59 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 177.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -144.33 154.77 43.38 Favored 'General case' 0 C--N 1.277 -2.585 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.3 ttpt -96.88 108.66 21.4 Favored 'General case' 0 CA--C 1.482 -1.64 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 174.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.9 t -110.05 131.62 60.56 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.198 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 18.2 tt0 -109.18 110.77 22.07 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 30' ' ' HIS . 97.5 mt -57.96 144.95 37.59 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.048 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -68.59 -5.63 21.01 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.825 0.821 . . . . 0.0 111.513 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -91.49 0.43 57.51 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.192 176.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.83 1.59 59.95 Favored Glycine 0 CA--C 1.532 1.153 0 N-CA-C 115.394 0.918 . . . . 0.0 115.394 174.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.453 ' HB3' HD12 ' A' ' 26' ' ' LEU . 19.5 t-80 -96.19 134.19 39.58 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 178.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.2 pt-20 -96.31 137.28 35.62 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' A' ' 63' ' ' THR . 35.2 pt -132.62 151.87 35.32 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.039 0 CA-C-O 121.658 0.742 . . . . 0.0 110.093 -175.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB2' ' NH1' ' A' ' 64' ' ' ARG . 31.0 mt -102.38 123.95 47.07 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 174.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -135.07 158.6 43.94 Favored 'General case' 0 C--N 1.28 -2.447 0 O-C-N 123.45 0.469 . . . . 0.0 110.964 -171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -113.4 137.45 51.5 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 123.493 0.496 . . . . 0.0 109.861 -175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 m -83.83 146.98 6.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.084 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.8 p -63.91 159.77 19.07 Favored 'General case' 0 C--O 1.247 0.95 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.046 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.05 -21.07 30.06 Favored Glycine 0 C--O 1.215 -1.075 0 CA-C-N 115.946 -0.57 . . . . 0.0 113.086 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -66.91 -32.07 73.07 Favored 'General case' 0 C--O 1.217 -0.651 0 CA-C-O 121.377 0.608 . . . . 0.0 109.868 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 47' ' ' ILE . 94.3 mt -90.56 -22.92 6.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.188 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.407 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -81.6 -44.39 17.32 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.512 -179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.407 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 26.7 ptt? -75.68 -23.5 56.2 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -175.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.412 ' HB3' HG12 ' A' ' 45' ' ' ILE . 19.1 t-20 -115.26 177.9 4.49 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 -175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -89.33 10.71 21.36 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -177.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 43' ' ' ASN . 33.4 pt -82.96 40.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.247 0.954 0 CA-C-O 122.046 0.927 . . . . 0.0 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -67.42 150.62 48.67 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.687 -1.597 . . . . 0.0 111.625 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.541 ' CG2' HG11 ' A' ' 13' ' ' VAL . 49.6 mm -83.38 133.38 29.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.903 -176.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.4 tp -118.91 137.99 25.6 Favored Pre-proline 0 C--N 1.3 -1.552 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.07 132.75 23.18 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.933 2.422 . . . . 0.0 111.879 175.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.1 -7.67 48.45 Favored Glycine 0 N--CA 1.433 -1.558 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.36 157.27 20.57 Favored 'General case' 0 N--CA 1.437 -1.12 0 C-N-CA 120.314 -0.554 . . . . 0.0 111.34 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 71' ' ' TYR . 6.8 tmtt? -112.88 125.18 54.09 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 103.717 -2.697 . . . . 0.0 103.717 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 25.1 m -134.03 156.36 40.81 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 -171.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.7 m -96.07 116.52 29.1 Favored 'General case' 0 C--O 1.267 1.978 0 CA-C-N 114.46 -1.245 . . . . 0.0 108.458 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.9 p -113.12 130.69 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 121.904 0.859 . . . . 0.0 111.09 -176.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -95.88 125.68 40.61 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 177.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.639 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -143.95 154.62 43.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 123.41 0.443 . . . . 0.0 111.5 -177.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.519 ' HB2' ' OD1' ' A' ' 61' ' ' ASP . 17.6 m -76.92 142.55 69.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 -178.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -64.68 -13.12 37.22 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 123.189 2.592 . . . . 0.0 112.185 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -87.56 -16.26 35.1 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.729 -177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.519 ' OD1' ' HB2' ' A' ' 58' ' ' SER . 4.6 p-10 -123.06 -59.02 1.61 Allowed 'General case' 0 C--O 1.247 0.971 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.639 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.9 mp 56.95 30.33 17.88 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.806 0.812 . . . . 0.0 110.301 -174.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.412 ' HA ' HG22 ' A' ' 32' ' ' ILE . 2.4 m -126.36 -28.11 3.11 Favored 'General case' 1 N--CA 1.358 -5.072 0 C-N-CA 124.303 1.041 . . . . 0.0 110.61 -175.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.472 ' NH1' ' HB2' ' A' ' 33' ' ' LEU . 5.0 tpp180 -124.22 142.44 51.24 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.887 -1.524 . . . . 0.0 106.887 178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.4 177.58 32.5 Favored Glycine 0 N--CA 1.427 -1.931 0 C-N-CA 118.36 -1.876 . . . . 0.0 112.572 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 135.71 46.5 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 123.188 0.595 . . . . 0.0 109.487 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -97.73 121.15 47.96 Favored 'Isoleucine or valine' 0 C--O 1.258 1.509 0 CA-C-O 121.32 0.581 . . . . 0.0 111.336 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.3 p -113.45 -20.95 11.11 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.88 164.1 32.09 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.1 ptp180 -130.29 114.71 15.97 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 92.1 t80 -106.59 124.93 50.34 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.442 177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.431 ' HE3' ' H ' ' A' ' 52' ' ' LYS . 77.9 mttt . . . . . 0 C--N 1.304 -1.41 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.498 171.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 C--O 1.211 -0.963 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.53 -169.58 1.77 Allowed 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -78.57 87.24 4.53 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 177.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -110.61 7.86 22.57 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.697 -176.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.9 157.61 16.75 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 113.686 -1.597 . . . . 0.0 110.832 -177.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.25 142.37 43.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 63.3 mt -133.73 148.78 30.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 44.8 mt-10 -101.1 127.8 47.47 Favored 'General case' 0 N--CA 1.432 -1.36 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 177.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.5 mt -121.84 162.71 20.46 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.469 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 10.7 mm-40 -107.07 146.82 30.74 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -152.67 173.75 31.63 Favored Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -125.82 127.62 46.37 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.545 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.0 p -88.26 132.3 33.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.5 mt -99.28 -41.08 7.62 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.109 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -138.12 157.87 45.45 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.648 0.737 . . . . 0.0 111.801 -177.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 37.9 p -100.61 120.33 39.88 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.343 -175.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.6 mt -95.51 149.89 36.74 Favored Pre-proline 0 C--N 1.314 -0.945 0 CA-C-O 121.156 0.503 . . . . 0.0 111.361 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -62.83 154.0 69.09 Favored 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.069 2.512 . . . . 0.0 112.062 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 74.24 27.54 1.49 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.189 0.996 . . . . 0.0 113.252 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.96 33.89 5.57 Favored 'General case' 0 C--O 1.249 1.066 0 C-N-CA 123.486 0.715 . . . . 0.0 110.881 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 7.0 tpt -110.39 159.89 17.06 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 104.953 -2.24 . . . . 0.0 104.953 176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.2 146.08 32.48 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -93.82 105.24 17.27 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 174.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.3 t -114.03 134.96 55.24 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.987 -175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.75 119.72 39.23 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.8 mt -61.86 159.61 13.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.494 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 3.5 mm-40 -59.77 -19.77 52.47 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 122.145 0.974 . . . . 0.0 109.045 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -77.63 -7.72 56.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.203 1.401 . . . . 0.0 111.855 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.91 10.37 78.95 Favored Glycine 0 C--O 1.222 -0.6 0 C-N-CA 120.269 -0.967 . . . . 0.0 111.892 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -94.78 140.94 29.22 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -178.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -96.24 135.98 37.33 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.466 HG22 ' HA ' ' A' ' 63' ' ' THR . 43.3 pt -134.35 148.15 29.89 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 CA-C-O 121.066 0.46 . . . . 0.0 109.794 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 78.6 mt -102.2 123.4 45.97 Favored 'General case' 0 N--CA 1.416 -2.165 0 N-CA-C 104.567 -2.383 . . . . 0.0 104.567 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.98 146.03 50.79 Favored 'General case' 0 C--N 1.272 -2.771 0 C-N-CA 119.549 -0.86 . . . . 0.0 110.722 -175.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 38.1 t-80 -112.44 147.32 36.74 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -178.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.499 ' HA ' ' HB ' ' A' ' 67' ' ' ILE . 26.7 m -82.5 148.8 4.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 121.236 -0.186 . . . . 0.0 111.386 177.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 71.4 p -63.6 160.51 16.58 Favored 'General case' 0 C--O 1.249 1.075 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.74 -178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.74 -26.71 60.6 Favored Glycine 0 N--CA 1.436 -1.319 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.429 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -78.2 -32.06 49.79 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.564 HG23 HG21 ' A' ' 45' ' ' ILE . 19.7 mt -79.12 -36.25 18.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.592 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 36.4 ttp180 -62.1 -37.31 84.61 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-O 121.378 0.608 . . . . 0.0 110.213 177.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.2 mtt -75.5 -18.24 59.88 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.717 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -98.71 148.49 23.8 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 -171.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -78.0 83.55 4.3 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.722 0.772 . . . . 0.0 109.117 174.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.564 HG21 HG23 ' A' ' 40' ' ' ILE . 2.1 pp -86.69 165.83 2.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.309 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -130.18 113.04 13.98 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mm -117.37 121.6 67.99 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 35.0 tp -111.66 138.02 21.4 Favored Pre-proline 0 C--N 1.278 -2.502 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -51.64 125.81 17.9 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 121.465 1.443 . . . . 0.0 109.012 170.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.09 -3.55 35.45 Favored Glycine 0 N--CA 1.435 -1.382 0 C-N-CA 120.038 -1.077 . . . . 0.0 111.029 -172.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.43 ' HA ' ' NZ ' ' A' ' 72' ' ' LYS . 12.3 m-20 -82.27 155.87 24.62 Favored 'General case' 0 CA--C 1.482 -1.662 0 O-C-N 122.418 -0.46 . . . . 0.0 110.594 174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.483 ' HB3' ' HZ2' ' A' ' 52' ' ' LYS . 6.2 mtpm? -112.1 146.75 37.43 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 34.4 m -134.58 149.02 29.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.626 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 10.0 m -95.47 117.53 30.56 Favored 'General case' 0 N--CA 1.403 -2.793 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 13.5 p -111.58 132.28 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.948 -174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -93.82 125.76 38.63 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 174.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.8 ptp -151.99 154.58 36.3 Favored 'General case' 0 C--N 1.287 -2.132 0 CA-C-O 121.531 0.682 . . . . 0.0 112.355 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 p -83.27 123.86 76.65 Favored Pre-proline 0 N--CA 1.385 -3.7 0 CA-C-N 114.49 -1.232 . . . . 0.0 108.007 175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -60.42 -12.48 20.69 Favored 'Trans proline' 0 N--CA 1.482 0.83 0 C-N-CA 123.549 2.833 . . . . 0.0 112.53 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -80.14 -16.4 54.98 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.943 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.659 ' OD1' ' HG2' ' A' ' 64' ' ' ARG . 13.1 t70 -107.62 -65.68 1.09 Allowed 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.449 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 5.2 tp 61.61 11.44 3.89 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 113.547 -1.661 . . . . 0.0 112.163 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 HG22 ' OD1' ' A' ' 61' ' ' ASP . 1.0 OUTLIER -114.61 -3.41 12.92 Favored 'General case' 0 N--CA 1.427 -1.608 0 O-C-N 121.432 -0.792 . . . . 0.0 109.519 176.777 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.659 ' HG2' ' OD1' ' A' ' 61' ' ' ASP . 10.2 ptt180 -155.53 152.4 28.81 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.032 178.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.21 -166.95 28.14 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -127.86 144.45 51.09 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.797 0.299 . . . . 0.0 111.128 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.499 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 mp -78.3 124.58 36.91 Favored 'Isoleucine or valine' 0 C--O 1.257 1.46 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.784 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.3 p -105.16 -24.5 12.74 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.135 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -158.59 160.96 37.15 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -129.25 127.53 41.4 Favored 'General case' 0 N--CA 1.436 -1.17 0 CA-C-O 121.081 0.467 . . . . 0.0 111.759 173.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -105.38 148.44 27.1 Favored 'General case' 0 C--N 1.289 -2.033 0 C-N-CA 123.897 0.879 . . . . 0.0 109.11 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.43 ' NZ ' ' HA ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.301 -1.518 0 CA-C-O 117.571 -1.204 . . . . 0.0 108.611 176.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 CA--C 1.502 -0.88 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.54 ' O ' ' HA ' ' A' ' 7' ' ' ILE . . . -127.45 106.34 9.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.6 mmtm -140.17 33.78 1.92 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.227 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HG3' ' H ' ' A' ' 5' ' ' ASP . 4.7 pt20 -138.7 -85.25 0.26 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.697 -177.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.449 ' H ' ' HG3' ' A' ' 4' ' ' GLN . 0.6 OUTLIER -76.41 -57.97 3.55 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 123.606 0.762 . . . . 0.0 110.733 178.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.3 t -105.49 155.53 6.58 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.779 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 173.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.54 ' HA ' ' O ' ' A' ' 2' ' ' ALA . 33.4 mm -127.18 128.62 70.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.23 133.65 46.76 Favored 'General case' 0 C--O 1.244 0.765 0 C-N-CA 118.131 -1.428 . . . . 0.0 108.515 172.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD12 ' SD ' ' A' ' 57' ' ' MET . 70.7 mt -128.67 161.38 29.8 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 -108.27 121.16 44.31 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.644 0.735 . . . . 0.0 109.946 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -125.28 166.89 17.81 Favored Glycine 0 N--CA 1.417 -2.592 0 C-N-CA 119.181 -1.485 . . . . 0.0 112.151 -178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.8 m -120.55 127.13 51.87 Favored 'General case' 0 C--N 1.276 -2.603 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 177.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.59 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.8 p -88.66 130.13 38.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.794 -176.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 8.1 mp -104.75 -34.86 7.97 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.501 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 4.9 m-20 -132.25 152.83 51.15 Favored 'General case' 0 C--O 1.246 0.874 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.487 -173.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.4 p -100.44 125.48 46.73 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.229 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.5 mt -109.96 150.52 41.51 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.925 0.393 . . . . 0.0 111.026 -176.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.11 153.49 78.05 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.871 2.381 . . . . 0.0 112.449 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 73.52 33.18 1.1 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.829 0.852 . . . . 0.0 112.887 174.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.75 31.6 9.52 Favored 'General case' 0 C--O 1.25 1.079 0 CA-C-O 121.896 0.855 . . . . 0.0 110.471 176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.0 tpp -106.65 154.73 20.5 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -141.0 148.49 40.38 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 32.6 tttm -99.41 106.48 18.54 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.59 HG22 ' HB ' ' A' ' 13' ' ' VAL . 26.4 t -116.09 147.06 19.73 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.802 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.225 -175.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.21 132.17 54.37 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 120.885 0.374 . . . . 0.0 110.755 174.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.47 177.37 3.46 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.181 178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -63.94 -27.82 69.4 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 124.347 1.059 . . . . 0.0 108.935 178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -77.56 -7.36 56.2 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.737 -178.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.73 11.09 82.25 Favored Glycine 0 C--O 1.215 -1.041 0 C-N-CA 120.017 -1.087 . . . . 0.0 112.123 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.3 t60 -93.63 157.08 16.35 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.401 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.8 pm0 -94.49 139.3 31.33 Favored 'General case' 0 C--N 1.273 -2.746 0 C-N-CA 123.84 0.856 . . . . 0.0 108.781 -175.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.1 pt -136.47 143.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 CA-C-N 115.226 -0.897 . . . . 0.0 108.938 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 80.2 mt -102.29 123.0 45.33 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 176.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.64 159.18 28.41 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.565 -173.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -123.77 140.05 53.38 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.2 m -83.11 147.41 5.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.892 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.606 177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.449 ' OG ' ' HG2' ' A' ' 39' ' ' LYS . 88.9 p -63.14 160.32 15.65 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.314 -177.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -53.76 -22.43 18.45 Favored Glycine 0 C--O 1.222 -0.639 0 O-C-N 123.926 0.766 . . . . 0.0 114.208 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HG2' ' OG ' ' A' ' 37' ' ' SER . 23.1 pttp -74.75 -27.53 60.39 Favored 'General case' 0 C--O 1.205 -1.27 0 CA-C-N 117.978 0.889 . . . . 0.0 110.772 -177.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.413 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 68.9 mt -88.19 -16.65 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 CA-C-O 122.319 1.057 . . . . 0.0 108.74 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -39.54 24.84 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -76.83 -47.22 22.05 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.19 175.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 3.5 m-20 -112.06 115.75 29.41 Favored 'General case' 0 CA--C 1.482 -1.655 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -77.39 91.29 3.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-N 115.344 -0.844 . . . . 0.0 113.181 -172.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.405 ' HB ' HG23 ' A' ' 40' ' ' ILE . 15.2 mm -84.34 115.06 25.76 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.946 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 174.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -68.16 99.91 0.95 Allowed 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.188 -173.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.3 mm -84.23 132.65 31.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 31.5 tp -124.72 133.84 25.12 Favored Pre-proline 0 C--N 1.295 -1.795 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -175.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 45.7 Cg_exo -48.47 131.35 23.21 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.788 2.326 . . . . 0.0 111.602 171.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.77 -17.68 38.54 Favored Glycine 0 N--CA 1.427 -1.935 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.458 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -85.46 159.43 19.95 Favored 'General case' 0 C--O 1.251 1.166 0 C-N-CA 120.354 -0.539 . . . . 0.0 110.339 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -102.09 142.3 33.58 Favored 'General case' 0 C--N 1.29 -2.018 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.454 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 15.7 m -138.5 154.08 26.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.195 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.4 m -96.13 120.04 35.71 Favored 'General case' 0 C--O 1.273 2.305 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.26 128.33 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.46 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.553 -176.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -95.4 125.99 40.39 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.705 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 13.6 ptp -145.39 154.24 42.07 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.015 -178.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -91.68 150.55 41.15 Favored Pre-proline 0 C--N 1.284 -2.276 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.13 -15.86 42.34 Favored 'Trans proline' 0 N--CA 1.482 0.848 0 C-N-CA 122.587 2.191 . . . . 0.0 111.597 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -85.2 -16.86 38.9 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.884 177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' C ' ' H ' ' A' ' 63' ' ' THR . 18.8 m-20 -99.46 -90.76 0.3 Allowed 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.456 0.646 . . . . 0.0 109.774 -179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.705 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.0 tt 68.29 -25.94 0.13 Allowed 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 127.358 2.263 . . . . 0.0 112.083 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 61' ' ' ASP . 9.6 t -96.82 -9.45 28.7 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-O 122.505 1.145 . . . . 0.0 108.079 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.452 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 30.2 tpt180 -130.05 142.13 50.65 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -178.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -161.35 -179.79 36.28 Favored Glycine 0 N--CA 1.433 -1.522 0 C-N-CA 119.681 -1.247 . . . . 0.0 111.968 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 -133.14 137.99 46.48 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.6 123.02 49.79 Favored 'Isoleucine or valine' 0 C--O 1.263 1.766 0 CA-C-O 121.32 0.581 . . . . 0.0 111.27 178.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.3 p -117.3 -23.32 7.88 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.227 176.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -142.65 162.33 35.76 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 -174.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.542 ' HA ' ' HA ' ' A' ' 53' ' ' VAL . 15.3 ptm180 -130.46 106.28 8.42 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-O 121.424 0.63 . . . . 0.0 109.585 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -105.11 144.9 31.27 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.649 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--N 1.299 -1.615 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.15 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 CA--C 1.509 -0.6 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.46 -8.97 14.95 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 172.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -165.57 174.7 9.6 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 104.925 -2.25 . . . . 0.0 104.925 -178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -118.49 0.17 11.53 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -173.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.28 -44.06 69.18 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.998 0.904 . . . . 0.0 110.943 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 42.0 t -135.09 150.46 29.73 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 105.41 -2.07 . . . . 0.0 105.41 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 46.2 mm -104.92 125.53 59.89 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 CA-C-N 118.065 0.393 . . . . 0.0 110.942 -174.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -102.15 123.46 46.04 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.418 HD12 ' SD ' ' A' ' 57' ' ' MET . 72.5 mt -123.1 161.98 23.35 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -108.95 147.91 31.52 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.071 -0.652 . . . . 0.0 110.159 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -149.91 173.99 29.49 Favored Glycine 0 N--CA 1.435 -1.397 0 C-N-CA 120.776 -0.726 . . . . 0.0 111.511 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.7 m -123.44 127.52 48.53 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 3.9 p -88.49 131.37 36.14 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.6 mt -105.48 -35.81 7.35 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.895 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.48 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.0 m-20 -130.62 153.51 48.84 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.687 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 p -100.91 134.34 44.03 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.905 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD11 HD22 ' A' ' 33' ' ' LEU . 40.1 mt -109.8 149.96 40.67 Favored Pre-proline 0 C--N 1.315 -0.918 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.18 152.75 69.69 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.415 2.077 . . . . 0.0 112.499 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 71.42 28.95 2.82 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.8 0.84 . . . . 0.0 113.144 174.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 71.83 31.84 2.02 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.468 1.107 . . . . 0.0 112.296 175.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -103.5 158.86 16.06 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 172.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -141.34 147.75 38.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 122.165 -0.334 . . . . 0.0 110.625 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 33.6 tttm -99.97 106.25 18.03 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.3 t -113.45 145.98 18.65 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.711 0 CA-C-N 114.637 -1.165 . . . . 0.0 109.184 -175.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.78 133.02 53.4 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.314 173.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.459 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 69.7 mt -72.84 170.42 14.73 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.976 176.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE1' ' HB3' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -67.37 -26.94 66.72 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.22 175.086 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -73.96 -2.23 23.14 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.52 175.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.59 9.7 86.11 Favored Glycine 0 C--O 1.222 -0.613 0 O-C-N 121.691 -0.63 . . . . 0.0 114.123 173.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -95.8 158.85 15.26 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -94.58 139.51 31.09 Favored 'General case' 0 N--CA 1.395 -3.22 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' THR . 30.5 pt -129.19 136.95 58.33 Favored 'Isoleucine or valine' 1 C--N 1.242 -4.076 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 177.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.419 HD22 HD11 ' A' ' 17' ' ' LEU . 86.2 mt -101.19 123.3 45.11 Favored 'General case' 0 C--N 1.264 -3.122 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -125.12 155.37 40.0 Favored 'General case' 0 N--CA 1.395 -3.179 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.707 -172.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 47.6 m80 -116.36 130.43 56.77 Favored 'General case' 0 N--CA 1.416 -2.125 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 20' ' ' ALA . 23.9 m -82.82 145.79 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 C-N-CA 118.006 -1.477 . . . . 0.0 110.837 176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.4 p -65.97 161.22 21.88 Favored 'General case' 0 C--N 1.31 -1.147 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.492 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 42' ' ' MET . . . -55.92 -17.23 15.01 Favored Glycine 0 CA--C 1.532 1.132 0 CA-C-O 119.441 -0.644 . . . . 0.0 113.631 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -64.54 -46.02 84.64 Favored 'General case' 0 C--N 1.359 0.981 0 CA-C-O 122.444 1.116 . . . . 0.0 108.235 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.5 mt -84.86 -23.39 7.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.084 -172.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 64.7 mtt-85 -71.91 -48.0 48.61 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.566 179.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER -76.65 -45.31 30.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 113.227 0.825 . . . . 0.0 113.227 179.611 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -86.37 172.39 10.45 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -175.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.67 20.83 10.23 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 29.6 pt -83.93 39.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-O 121.935 0.874 . . . . 0.0 109.027 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -79.68 147.75 31.85 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 113.935 -1.484 . . . . 0.0 112.489 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.591 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.51 133.02 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.27 -175.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.5 mp -119.71 140.61 29.74 Favored Pre-proline 0 C--N 1.304 -1.392 0 C-N-CA 124.859 1.264 . . . . 0.0 109.966 176.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -41.91 126.71 3.52 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.895 2.397 . . . . 0.0 111.751 177.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.27 -17.62 34.16 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.495 -173.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.527 ' OD1' ' HD2' ' A' ' 70' ' ' ARG . 0.7 OUTLIER -66.09 146.69 54.37 Favored 'General case' 0 C--O 1.257 1.477 0 CA-C-O 121.396 0.617 . . . . 0.0 111.259 175.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -103.64 126.1 50.57 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 30.0 m -124.18 158.38 30.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 C-N-CA 119.194 -1.002 . . . . 0.0 112.401 -176.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.5 m -99.22 120.42 39.5 Favored 'General case' 0 N--CA 1.41 -2.474 0 N-CA-C 105.882 -1.895 . . . . 0.0 105.882 173.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.4 p -108.41 131.97 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.04 0 CA-C-O 121.695 0.76 . . . . 0.0 110.262 -175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.38 126.0 40.39 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.792 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 6.5 ptp -144.68 151.72 39.36 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-O 121.116 0.484 . . . . 0.0 111.363 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.8 m -67.31 141.92 96.31 Favored Pre-proline 0 C--N 1.302 -1.483 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.046 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -62.07 -13.75 33.47 Favored 'Trans proline' 0 N--CA 1.486 1.066 0 C-N-CA 122.894 2.396 . . . . 0.0 112.693 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -107.72 5.99 27.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.818 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.6 -81.07 0.57 Allowed 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.323 -178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.792 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.4 mp 61.71 16.45 7.82 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 32' ' ' ILE . 10.6 t -127.52 -26.13 3.06 Favored 'General case' 0 N--CA 1.423 -1.801 0 CA-C-O 121.498 0.666 . . . . 0.0 110.342 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.65 156.84 30.87 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 125.375 1.47 . . . . 0.0 107.543 178.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -163.98 -169.3 27.31 Favored Glycine 0 C--O 1.258 1.627 0 C-N-CA 118.174 -1.965 . . . . 0.0 115.267 179.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.4 ttm-85 -135.57 142.05 45.26 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.844 1.258 . . . . 0.0 108.362 178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.3 mp -90.5 118.91 36.69 Favored 'Isoleucine or valine' 0 C--O 1.257 1.463 0 CA-C-O 121.476 0.655 . . . . 0.0 109.375 175.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 13.6 p -100.32 -23.31 14.82 Favored 'General case' 0 C--N 1.281 -2.411 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.838 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -165.78 152.86 10.1 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.527 ' HD2' ' OD1' ' A' ' 51' ' ' ASP . 35.5 ptt180 -111.06 135.33 51.73 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 171.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -104.13 126.1 50.97 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 123.536 0.522 . . . . 0.0 110.87 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 178.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' H2 ' ' HG2' ' A' ' 4' ' ' GLN . 1.8 mpt? . . . . . 0 CA--C 1.511 -0.551 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.71 -36.55 67.31 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.94 0.876 . . . . 0.0 109.078 175.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -125.78 149.49 48.53 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 169.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG2' ' H2 ' ' A' ' 1' ' ' MET . 41.8 mt-30 -108.95 89.35 2.96 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 119.023 -1.071 . . . . 0.0 111.683 -177.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.75 -32.44 65.66 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 143.55 39.89 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 102.826 -3.027 . . . . 0.0 102.826 173.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.462 HG22 ' HG ' ' A' ' 9' ' ' LEU . 57.6 mt -104.34 122.28 57.05 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.86 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.418 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 2.2 mp0 -101.37 116.4 32.7 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.462 ' HG ' HG22 ' A' ' 7' ' ' ILE . 85.5 mt -129.63 161.43 30.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.94 159.2 35.68 Favored 'General case' 0 C--N 1.264 -3.14 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 176.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -163.72 175.87 39.86 Favored Glycine 0 N--CA 1.409 -3.156 0 C-N-CA 119.186 -1.483 . . . . 0.0 112.324 -177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.7 m -94.87 131.11 41.11 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 123.913 0.885 . . . . 0.0 110.003 -177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 2.7 p -88.41 132.04 34.41 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 120.094 -0.642 . . . . 0.0 111.523 178.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.78 -35.24 7.82 Favored 'General case' 0 C--N 1.312 -1.037 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.546 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.3 m-20 -132.37 149.43 52.35 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.683 -175.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.8 p -100.07 126.58 46.31 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 mt -110.21 150.04 40.96 Favored Pre-proline 0 N--CA 1.442 -0.864 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -65.44 155.29 69.59 Favored 'Trans proline' 0 CA--C 1.541 0.829 0 C-N-CA 123.641 2.894 . . . . 0.0 112.043 173.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 74.54 28.77 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.82 0.848 . . . . 0.0 112.734 175.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' O ' HG22 ' A' ' 36' ' ' VAL . . . 64.94 33.53 9.77 Favored 'General case' 0 C--O 1.246 0.882 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.411 176.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 25.2 tpp -108.37 159.21 16.84 Favored 'General case' 0 C--N 1.312 -1.044 0 N-CA-C 105.275 -2.12 . . . . 0.0 105.275 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -141.21 145.0 35.06 Favored 'General case' 0 C--N 1.269 -2.906 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.546 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 57.8 tttm -100.12 102.67 14.05 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 t -111.48 149.05 14.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 114.253 -1.34 . . . . 0.0 108.26 -173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 34.6 tt0 -115.26 125.95 53.93 Favored 'General case' 0 C--N 1.273 -2.752 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.78 148.51 47.83 Favored 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -61.3 -6.31 2.1 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 124.101 0.96 . . . . 0.0 111.691 -177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.69 -7.17 57.75 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 123.892 0.877 . . . . 0.0 109.01 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.62 9.0 60.45 Favored Glycine 0 C--O 1.221 -0.704 0 C-N-CA 120.999 -0.62 . . . . 0.0 112.573 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -95.95 131.36 42.4 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 7.7 pt-20 -95.59 142.22 28.18 Favored 'General case' 0 C--N 1.273 -2.73 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 175.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.509 HG22 ' HA ' ' A' ' 63' ' ' THR . 36.9 pt -135.17 152.58 32.61 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.862 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.765 -173.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.517 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 57.5 mt -106.97 123.72 48.59 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.16 155.34 49.69 Favored 'General case' 0 C--N 1.276 -2.609 0 C-N-CA 119.6 -0.84 . . . . 0.0 111.194 -174.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 29.9 t-80 -111.96 147.46 35.85 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.001 0.429 . . . . 0.0 109.915 -176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ALA . 30.7 m -82.66 149.85 4.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.999 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.8 p -62.72 162.18 11.2 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 121.816 0.817 . . . . 0.0 110.978 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.428 ' HA2' ' NE ' ' A' ' 41' ' ' ARG . . . -53.6 -18.15 7.39 Favored Glycine 0 N--CA 1.431 -1.643 0 CA-C-N 114.726 -1.125 . . . . 0.0 114.619 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -78.13 -34.34 49.93 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 118.101 0.951 . . . . 0.0 110.199 -177.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 98.5 mt -79.71 -14.93 13.25 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.841 0 CA-C-O 121.931 0.872 . . . . 0.0 109.85 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.428 ' NE ' ' HA2' ' A' ' 38' ' ' GLY . 65.7 mtm180 -72.58 -38.7 67.8 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.1 ttt -74.96 -45.23 43.66 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.965 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' ILE . 15.3 m120 -123.46 91.86 3.57 Favored 'General case' 0 CA--C 1.478 -1.804 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -74.14 90.56 2.05 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.817 -1.083 . . . . 0.0 112.626 -174.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 33.3 pt -82.33 122.99 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.204 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.65 174.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.5 mtt-85 -83.18 114.09 21.1 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.395 -176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -89.95 127.53 42.47 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.2 mp -96.09 139.67 21.9 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -176.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 13' ' ' VAL . 65.7 Cg_exo -43.52 126.01 5.11 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 123.2 2.6 . . . . 0.0 111.985 175.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.4 -15.31 38.92 Favored Glycine 0 N--CA 1.436 -1.302 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.532 -175.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -84.6 159.59 20.6 Favored 'General case' 0 C--O 1.252 1.233 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.4 mtpt -113.67 139.97 48.62 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.5 m -134.52 156.4 40.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.502 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 69' ' ' TYR . 8.5 m -101.84 122.67 44.43 Favored 'General case' 0 C--O 1.264 1.845 0 CA-C-O 121.144 0.497 . . . . 0.0 109.668 -179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 15.0 p -113.61 133.02 60.89 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.289 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -95.5 125.17 39.92 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.78 154.48 50.21 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.29 0.567 . . . . 0.0 110.594 -178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -80.7 139.81 50.84 Favored Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -62.34 -19.42 67.08 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 C-N-CA 122.926 2.418 . . . . 0.0 112.419 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -97.79 6.65 47.58 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.77 -179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -126.0 -75.9 0.59 Allowed 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.408 -177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.3 tp 56.09 21.18 4.91 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 125.804 1.641 . . . . 0.0 112.583 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.509 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.0 t -128.05 -16.78 4.5 Favored 'General case' 0 N--CA 1.431 -1.385 0 O-C-N 121.39 -0.819 . . . . 0.0 111.844 175.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.47 145.85 49.28 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 125.774 1.629 . . . . 0.0 107.814 173.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -160.3 -175.69 31.57 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 119.447 -1.359 . . . . 0.0 113.092 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 7.7 tmm_? -134.26 132.68 39.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -178.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.1 mp -97.12 124.77 50.15 Favored 'Isoleucine or valine' 0 C--O 1.253 1.278 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.8 p -113.57 -24.82 9.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.896 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.452 ' HB3' ' HB ' ' A' ' 54' ' ' THR . 73.3 t80 -122.76 140.62 52.7 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-O 121.24 0.543 . . . . 0.0 109.849 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.512 ' N ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -132.0 138.25 48.18 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 178.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -83.38 148.1 27.5 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.835 ' NZ ' ' HA ' ' A' ' 72' ' ' LYS 0.397 0.0 OUTLIER . . . . . 0 N--CA 1.414 -2.261 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 176.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.58 123.21 1.26 Allowed 'General case' 0 C--O 1.223 -0.301 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' HD3' ' OD2' ' A' ' 5' ' ' ASP . 42.9 mttp -145.79 170.57 16.27 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 124.278 1.031 . . . . 0.0 108.763 173.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -135.14 19.85 3.43 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 3' ' ' LYS . 4.4 p-10 -136.06 -66.17 0.56 Allowed 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 113.868 -1.514 . . . . 0.0 110.428 -171.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.2 t -104.91 161.24 4.94 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.471 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 175.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 48.8 mm -103.62 117.27 48.84 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 7.9 pt-20 -112.81 130.16 56.18 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.441 178.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 71.4 mt -121.49 161.74 21.74 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.355 -177.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 53' ' ' VAL . 6.6 mp0 -107.43 139.68 41.56 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.47 171.62 31.0 Favored Glycine 0 N--CA 1.427 -1.946 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.0 m -116.29 127.84 55.05 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.564 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.8 p -88.89 128.88 40.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.125 0 CA-C-O 120.912 0.387 . . . . 0.0 112.001 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.603 HD23 ' H ' ' A' ' 14' ' ' LEU . 1.8 pt? -106.26 -33.15 7.89 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.909 178.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' OD2' ' HG ' ' A' ' 14' ' ' LEU . 14.4 m-20 -125.28 148.74 48.56 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-O 121.323 0.582 . . . . 0.0 110.444 -171.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 17.6 p -100.14 123.9 44.92 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.133 -0.94 . . . . 0.0 109.284 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 59.0 mt -109.96 150.46 41.43 Favored Pre-proline 0 C--N 1.306 -1.318 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.268 -178.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -60.25 152.38 66.87 Favored 'Trans proline' 0 CA--C 1.547 1.128 0 C-N-CA 122.622 2.215 . . . . 0.0 113.138 178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 63.9 t30 72.08 28.15 2.55 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.276 1.031 . . . . 0.0 111.931 175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.53 35.07 5.65 Favored 'General case' 0 C--O 1.25 1.107 0 CA-C-O 121.783 0.801 . . . . 0.0 110.694 177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.457 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 7.2 tpt -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 175.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -143.69 150.82 39.26 Favored 'General case' 0 C--N 1.262 -3.198 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' HE2' HD21 ' A' ' 14' ' ' LEU . 13.5 ttpt -95.37 108.04 20.21 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 174.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 HG22 ' HB ' ' A' ' 13' ' ' VAL . 25.3 t -109.68 134.5 51.56 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.091 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 -176.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 10.7 tt0 -111.12 111.77 23.09 Favored 'General case' 0 N--CA 1.398 -3.056 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 -176.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.38 144.64 56.79 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.439 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' H ' ' HG2' ' A' ' 27' ' ' GLU . 4.3 pt-20 -69.06 -5.01 19.31 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-O 121.944 0.878 . . . . 0.0 112.742 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -7.31 59.55 Favored 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 114.706 -1.134 . . . . 0.0 108.173 173.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.17 2.89 59.06 Favored Glycine 0 C--O 1.22 -0.767 0 C-N-CA 121.499 -0.381 . . . . 0.0 113.654 177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -96.37 135.34 38.35 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 8.9 pt-20 -96.32 141.21 29.92 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 173.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.464 HG21 ' HE1' ' A' ' 57' ' ' MET . 39.7 pt -135.85 152.08 30.34 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.804 0 CA-C-O 121.154 0.502 . . . . 0.0 109.719 -175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 50.8 mt -102.35 123.59 46.42 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 104.718 -2.327 . . . . 0.0 104.718 176.169 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.82 155.39 49.05 Favored 'General case' 0 C--N 1.279 -2.495 0 C-N-CA 119.806 -0.758 . . . . 0.0 111.442 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 22.5 t-80 -115.41 139.5 49.96 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.277 -175.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 147.36 5.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 60.4 p -64.47 160.45 19.25 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 120.946 0.403 . . . . 0.0 110.493 -178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.09 -23.85 48.45 Favored Glycine 0 C--O 1.221 -0.677 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.109 177.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -73.03 -33.46 65.73 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.322 0.582 . . . . 0.0 109.845 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.42 HG21 HD13 ' A' ' 47' ' ' ILE . 94.4 mt -83.35 -34.43 10.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.141 -179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -65.4 -45.19 84.93 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.54 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.8 mtt -75.91 -46.82 27.99 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -86.32 172.11 10.7 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 116.666 -0.243 . . . . 0.0 111.009 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -83.41 6.29 20.6 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.532 0.733 . . . . 0.0 112.098 -175.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.9 pt -81.78 37.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 121.332 -0.855 . . . . 0.0 111.142 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -76.64 150.87 36.36 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 125.022 1.329 . . . . 0.0 114.414 -170.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.564 ' CG2' HG11 ' A' ' 13' ' ' VAL . 2.2 mp -83.61 133.71 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 113.275 -1.784 . . . . 0.0 110.668 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.2 tp -126.09 139.93 35.66 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -39.83 127.88 1.9 Allowed 'Trans proline' 0 CA--C 1.544 1.017 0 C-N-CA 122.041 1.827 . . . . 0.0 112.01 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.81 -20.11 29.7 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.594 -173.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.08 143.11 56.87 Favored 'General case' 0 C--O 1.258 1.5 0 CA-C-O 121.04 0.448 . . . . 0.0 110.763 175.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.6 mttt -102.19 128.52 48.66 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 10' ' ' GLU . 34.3 m -122.02 156.85 26.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -173.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 63.6 m -96.24 114.58 26.28 Favored 'General case' 0 N--CA 1.412 -2.369 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.7 p -110.18 124.8 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.181 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.205 -177.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -95.0 125.81 39.92 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 179.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.659 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 5.6 ptp -144.83 154.63 42.87 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.027 -176.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.3 m -74.82 140.12 74.19 Favored Pre-proline 0 N--CA 1.421 -1.907 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -65.55 -13.73 41.27 Favored 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 122.675 2.25 . . . . 0.0 112.06 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -100.66 5.33 43.77 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.502 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -114.82 -78.17 0.58 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.659 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 1.0 OUTLIER 58.4 22.07 9.07 Favored 'General case' 0 CA--C 1.565 1.542 0 C-N-CA 125.171 1.389 . . . . 0.0 111.809 177.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.435 ' HA ' HG22 ' A' ' 32' ' ' ILE . 6.7 t -128.1 -19.18 4.0 Favored 'General case' 0 N--CA 1.435 -1.202 0 O-C-N 121.247 -0.908 . . . . 0.0 111.492 174.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.9 151.37 45.45 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 125.357 1.463 . . . . 0.0 108.369 174.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.01 -179.62 36.77 Favored Glycine 0 N--CA 1.431 -1.695 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.378 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.2 ttm180 -132.21 136.14 46.8 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.66 120.86 47.54 Favored 'Isoleucine or valine' 0 C--O 1.255 1.357 0 CA-C-O 121.149 0.5 . . . . 0.0 111.096 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.1 p -111.9 -23.03 10.78 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.781 173.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -137.4 141.67 41.69 Favored 'General case' 0 N--CA 1.433 -1.276 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.459 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -131.48 138.99 49.23 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -84.17 124.72 31.46 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 26.7 tptt . . . . . 0 N--CA 1.427 -1.612 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -176.499 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HG3' ' OE2' ' A' ' 8' ' ' GLU . 67.8 mtt . . . . . 0 C--O 1.212 -0.892 0 CA-C-O 120.248 0.07 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.39 -41.5 60.85 Favored 'General case' 0 C--O 1.214 -0.788 0 CA-C-O 121.511 0.672 . . . . 0.0 110.595 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -128.8 135.48 49.21 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -97.05 68.8 2.31 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.279 0.561 . . . . 0.0 111.651 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -82.78 -29.79 29.37 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 175.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 59.7 t -132.05 144.39 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.99 136.22 39.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.41 ' OE2' ' HG3' ' A' ' 1' ' ' MET . 4.2 mp0 -101.48 116.5 32.92 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.468 HD12 ' SD ' ' A' ' 57' ' ' MET . 83.1 mt -121.99 161.5 22.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -126.01 122.22 35.25 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.762 0.791 . . . . 0.0 110.729 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -120.12 170.67 14.3 Favored Glycine 0 N--CA 1.413 -2.894 0 C-N-CA 119.951 -1.118 . . . . 0.0 112.212 -176.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.6 m -113.15 127.17 56.11 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.2 p -88.04 127.07 41.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.989 -178.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.453 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 69.5 mt -103.59 -34.13 8.75 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.978 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.47 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -131.62 148.67 52.62 Favored 'General case' 0 C--N 1.312 -1.037 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.752 -175.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.8 p -100.4 128.76 46.38 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.547 -177.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 63.4 mt -109.96 150.66 41.71 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 120.797 0.332 . . . . 0.0 110.66 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 17' ' ' LEU . 20.8 Cg_exo -67.45 153.76 75.71 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.74 2.293 . . . . 0.0 112.479 175.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 72.87 35.63 0.99 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.921 0.889 . . . . 0.0 112.844 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 66.06 25.51 10.87 Favored 'General case' 0 C--O 1.247 0.938 0 C-N-CA 123.944 0.898 . . . . 0.0 111.225 175.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.47 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 3.3 tpp -99.81 151.7 20.97 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 175.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -138.17 144.63 40.82 Favored 'General case' 0 C--N 1.274 -2.706 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 11.4 tmtt? -97.9 106.08 18.32 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 ' HB ' ' A' ' 13' ' ' VAL . 21.8 t -120.8 148.75 23.85 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.711 -171.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -110.07 133.07 53.58 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 172.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' HB3' ' OE1' ' A' ' 27' ' ' GLU . 83.9 mt -67.88 170.56 7.91 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.954 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -72.72 -20.76 61.15 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 176.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -74.02 -7.97 54.4 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 113.606 -1.634 . . . . 0.0 110.977 175.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.5 10.63 81.52 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.994 178.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.2 t-80 -94.99 156.69 16.21 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.8 pm0 -94.23 135.5 35.54 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.99 146.06 26.64 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 CA-C-O 121.737 0.779 . . . . 0.0 110.072 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 64' ' ' ARG . 90.1 mt -102.27 123.0 45.32 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 174.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.491 ' HB1' ' CD1' ' A' ' 67' ' ' ILE . . . -120.29 159.72 24.42 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.419 -172.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -134.92 133.61 39.78 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.4 m -82.85 147.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 120.929 0.395 . . . . 0.0 111.269 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.3 p -64.31 160.5 18.67 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.508 -178.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.79 -20.26 59.48 Favored Glycine 0 N--CA 1.438 -1.18 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.56 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -71.57 -39.28 70.7 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.529 HG23 HG21 ' A' ' 45' ' ' ILE . 28.5 mt -74.75 -42.17 47.44 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.705 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.507 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 1.1 tmm_? -62.68 -39.29 93.5 Favored 'General case' 0 CA--C 1.553 1.068 0 CA-C-O 120.991 0.424 . . . . 0.0 110.2 -178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 67.4 mtt -75.59 -18.91 59.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 -177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -107.79 169.71 8.43 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 119.723 -0.791 . . . . 0.0 112.333 -175.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -78.85 81.65 5.12 Favored 'General case' 0 C--O 1.25 1.125 0 CA-C-O 121.578 0.704 . . . . 0.0 109.627 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.529 HG21 HG23 ' A' ' 40' ' ' ILE . 2.7 pp -91.73 157.38 2.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.504 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -129.88 98.27 4.74 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.343 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -113.35 123.6 69.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 176.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.411 HD12 ' HD2' ' A' ' 49' ' ' PRO . 29.3 tp -126.7 138.43 32.51 Favored Pre-proline 0 C--N 1.284 -2.26 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 10.8 Cg_exo -42.34 125.56 3.54 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.238 1.958 . . . . 0.0 111.477 171.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.16 -5.8 36.33 Favored Glycine 0 N--CA 1.434 -1.499 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.322 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -83.88 158.11 21.74 Favored 'General case' 0 C--O 1.252 1.199 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 40.0 tttm -113.23 129.83 56.41 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.229 -176.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.6 m -131.74 157.72 43.19 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-O 120.868 0.366 . . . . 0.0 111.838 -178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 6.6 m -97.04 115.04 26.76 Favored 'General case' 0 C--O 1.272 2.263 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 -179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.4 p -114.4 133.64 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.19 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.895 -174.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -102.26 134.74 45.05 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.678 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 7.6 ptp -152.23 155.39 37.65 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 123.123 0.569 . . . . 0.0 111.115 -177.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 82.5 p -74.7 149.72 86.07 Favored Pre-proline 0 N--CA 1.435 -1.211 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -62.06 -13.06 29.31 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.597 2.198 . . . . 0.0 111.942 177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.1 t80 -99.67 -16.48 18.17 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.691 -176.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.39 -70.68 0.76 Allowed 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 118.009 -1.476 . . . . 0.0 113.967 -176.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.678 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 10.7 mp 58.19 28.46 16.56 Favored 'General case' 0 C--O 1.252 1.189 0 C-N-CA 124.065 0.946 . . . . 0.0 112.044 -174.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.9 t -128.38 -24.05 3.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.916 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD2' ' O ' ' A' ' 33' ' ' LEU . 26.8 tpt180 -128.39 132.35 48.52 Favored 'General case' 0 C--O 1.203 -1.344 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -177.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.33 165.58 28.64 Favored Glycine 0 N--CA 1.428 -1.9 0 C-N-CA 118.259 -1.924 . . . . 0.0 112.433 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -124.85 136.83 54.16 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.491 ' CD1' ' HB1' ' A' ' 34' ' ' ALA . 2.0 mp -97.3 117.9 42.78 Favored 'Isoleucine or valine' 0 C--O 1.256 1.419 0 CA-C-O 121.282 0.563 . . . . 0.0 111.312 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.94 -23.61 16.23 Favored 'General case' 0 C--N 1.286 -2.181 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.643 175.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -151.65 155.11 37.69 Favored 'General case' 0 N--CA 1.434 -1.226 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.108 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.546 HH21 ' H ' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -114.33 104.1 11.73 Favored 'General case' 0 CA--C 1.472 -2.049 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.166 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -109.13 119.56 39.9 Favored 'General case' 0 N--CA 1.396 -3.175 0 C-N-CA 117.35 -1.74 . . . . 0.0 109.089 170.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.546 ' H ' HH21 ' A' ' 70' ' ' ARG . 20.7 pttm . . . . . 0 C--N 1.273 -2.741 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 165.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 C--O 1.213 -0.852 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.643 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.58 -32.95 25.52 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.578 ' NZ ' ' HA ' ' A' ' 5' ' ' ASP . 0.0 OUTLIER -157.19 -151.72 0.33 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 103.638 -2.727 . . . . 0.0 103.638 175.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.53 -27.09 68.73 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 121.189 1.813 . . . . 0.0 109.992 177.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.578 ' HA ' ' NZ ' ' A' ' 3' ' ' LYS 0.437 15.1 m-20 85.39 19.43 0.11 Allowed 'General case' 0 CA--C 1.475 -1.925 0 CA-C-O 125.568 2.604 . . . . 0.0 113.504 179.419 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.7 t -103.83 171.78 1.61 Allowed 'Isoleucine or valine' 1 C--N 1.222 -4.97 2 CA-C-N 106.457 -4.883 . . . . 0.0 99.362 166.49 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 45.4 mm -102.44 114.72 42.73 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.191 0 C-N-CA 116.484 -2.087 . . . . 0.0 108.304 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.492 ' OE2' ' HB2' ' A' ' 3' ' ' LYS . 2.7 mp0 -103.09 116.58 32.79 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.255 -0.884 . . . . 0.0 108.806 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 84.5 mt -122.33 160.88 24.44 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.859 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.59 153.37 25.26 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.06 176.77 41.34 Favored Glycine 0 C--N 1.289 -2.036 0 C-N-CA 120.329 -0.938 . . . . 0.0 111.674 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 26.2 m -119.58 126.65 51.72 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.58 ' HB ' HG22 ' A' ' 24' ' ' VAL . 2.5 p -89.25 130.39 38.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 120.403 -0.519 . . . . 0.0 111.522 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 9.3 mp -104.43 -35.15 8.01 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -179.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 6.1 m-20 -133.43 150.67 51.76 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.774 -174.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.6 p -100.78 127.92 47.03 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 22.8 mt -109.76 150.63 41.56 Favored Pre-proline 0 C--N 1.316 -0.865 0 C-N-CA 120.687 -0.405 . . . . 0.0 109.921 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.16 152.79 69.38 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 122.578 2.186 . . . . 0.0 112.601 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.4 t30 73.41 27.44 1.88 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 124.385 1.074 . . . . 0.0 111.487 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 71.28 24.0 3.88 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.798 175.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.505 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.8 OUTLIER -86.8 148.99 25.16 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 172.351 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -134.79 137.91 43.81 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 38.0 tttm -94.18 105.35 17.35 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.58 HG22 ' HB ' ' A' ' 13' ' ' VAL . 23.1 t -114.02 139.88 37.47 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 CA-C-N 114.484 -1.235 . . . . 0.0 109.212 -175.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -106.26 133.76 50.46 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 173.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.75 158.87 33.4 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 52' ' ' LYS . 4.9 mm-40 -64.5 -7.13 9.0 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 121.89 0.852 . . . . 0.0 110.909 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -88.35 -7.41 56.72 Favored 'General case' 0 CA--C 1.553 1.059 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.59 10.03 65.84 Favored Glycine 0 C--O 1.216 -0.975 0 C-N-CA 121.16 -0.543 . . . . 0.0 113.33 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -96.22 157.06 16.07 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 3.7 pm0 -95.25 137.55 34.15 Favored 'General case' 0 C--N 1.28 -2.432 0 C-N-CA 124.051 0.94 . . . . 0.0 109.532 -177.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -139.65 150.08 22.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 176.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 88.8 mt -106.64 124.85 50.23 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -123.14 158.43 30.75 Favored 'General case' 0 C--N 1.283 -2.321 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.708 -176.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 34.8 t-80 -127.42 138.98 53.12 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 178.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.5 m -82.79 148.19 5.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.342 176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.3 p -64.16 161.21 16.77 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.948 -178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.39 -19.56 33.71 Favored Glycine 0 C--O 1.22 -0.778 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.697 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -66.95 -40.95 87.68 Favored 'General case' 0 C--N 1.345 0.381 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 45' ' ' ILE . 24.3 mt -77.5 -44.05 29.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.725 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' NH2' ' HA ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -60.79 -43.68 97.82 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.416 -178.217 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.492 ' HA ' ' NH2' ' A' ' 41' ' ' ARG . 15.9 tpt -71.29 -35.61 71.38 Favored 'General case' 0 C--O 1.217 -0.638 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -175.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 -89.97 0.53 57.04 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.035 0.445 . . . . 0.0 111.406 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 68.4 m-85 58.96 20.56 8.29 Favored 'General case' 0 C--O 1.253 1.238 0 C-N-CA 124.926 1.291 . . . . 0.0 113.993 178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.467 ' O ' HG23 ' A' ' 40' ' ' ILE . 13.8 pt -73.44 145.02 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 79.4 mtt180 -129.03 150.21 50.53 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 120.263 -0.575 . . . . 0.0 111.601 -168.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.5 mm -97.25 132.63 41.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 176.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.424 HD12 ' HD2' ' A' ' 49' ' ' PRO . 33.7 tp -94.0 137.74 22.9 Favored Pre-proline 0 C--N 1.297 -1.69 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -176.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 56.5 Cg_exo -49.85 125.68 15.0 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 121.856 1.704 . . . . 0.0 110.399 169.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.21 -4.69 38.27 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -176.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -83.87 154.96 23.16 Favored 'General case' 0 C--O 1.247 0.968 0 C-N-CA 122.556 0.342 . . . . 0.0 110.214 175.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -102.85 140.46 37.1 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 178.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.6 m -135.86 150.4 28.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.064 0 O-C-N 121.091 -1.006 . . . . 0.0 112.789 -175.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 25.8 m -95.36 114.47 26.25 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -111.71 123.97 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.001 0 CA-C-N 114.739 -1.118 . . . . 0.0 110.272 -176.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.438 ' CD ' HH21 ' A' ' 66' ' ' ARG . 21.7 mt-10 -97.31 125.38 41.86 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 177.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -132.5 154.22 50.15 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 21.1 m -71.1 139.62 85.17 Favored Pre-proline 0 C--N 1.292 -1.907 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.88 -14.62 33.49 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 C-N-CA 122.949 2.433 . . . . 0.0 113.538 -177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -109.71 10.63 24.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.303 0.573 . . . . 0.0 109.578 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -116.5 -79.07 0.58 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.224 -0.59 . . . . 0.0 111.353 -177.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp 59.75 20.88 9.65 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 HG23 ' NE ' ' A' ' 64' ' ' ARG . 3.3 t -127.28 -23.71 3.5 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.607 0.718 . . . . 0.0 110.692 174.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -117.55 137.84 52.31 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 124.808 1.243 . . . . 0.0 108.774 173.778 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -146.05 171.72 26.89 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.736 -1.221 . . . . 0.0 113.466 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.438 HH21 ' CD ' ' A' ' 56' ' ' GLU . 7.6 tmm_? -124.97 130.17 51.82 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mt -97.84 127.24 50.41 Favored 'Isoleucine or valine' 0 C--O 1.26 1.613 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.6 p -117.44 -23.73 7.64 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-N 113.324 -1.762 . . . . 0.0 113.636 174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -139.83 147.67 41.05 Favored 'General case' 0 C--N 1.318 -0.784 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.548 -175.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 52' ' ' LYS . 1.0 OUTLIER -130.33 125.15 33.96 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.429 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -104.62 148.08 26.93 Favored 'General case' 0 C--N 1.269 -2.912 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 51.2 tptt . . . . . 0 C--N 1.285 -2.214 0 CA-C-O 117.253 -1.356 . . . . 0.0 109.32 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mmt . . . . . 0 CA--C 1.503 -0.864 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.56 -33.68 41.58 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 175.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.459 ' HB3' ' OD1' ' A' ' 5' ' ' ASP . 10.0 mtmp? -128.28 179.22 5.74 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.527 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -141.2 18.95 2.26 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-O 121.726 0.774 . . . . 0.0 110.077 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.459 ' OD1' ' HB3' ' A' ' 3' ' ' LYS . 20.7 p-10 -98.46 -44.21 6.59 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 124.829 1.251 . . . . 0.0 109.182 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.37 166.62 3.93 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.376 0 CA-C-N 113.766 -1.561 . . . . 0.0 107.052 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 62.9 mt -102.13 119.74 50.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 -175.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 37.1 mt-10 -103.03 125.34 49.73 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 114.671 -1.15 . . . . 0.0 110.933 -178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 63.1 mt -121.69 161.24 22.89 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -110.31 166.64 10.81 Favored 'General case' 0 C--N 1.289 -2.046 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.963 177.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -164.42 170.53 39.63 Favored Glycine 0 N--CA 1.415 -2.702 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.175 176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.2 m -105.9 127.56 53.21 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.599 HG11 ' CG2' ' A' ' 47' ' ' ILE . 2.6 p -88.82 130.98 37.35 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.35 0 C-N-CA 120.295 -0.562 . . . . 0.0 111.481 -178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' H ' HD23 ' A' ' 14' ' ' LEU . 1.9 pt? -103.66 -34.36 8.64 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -140.98 158.55 43.78 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 121.258 0.551 . . . . 0.0 112.281 -173.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.3 p -107.91 123.32 48.44 Favored 'General case' 0 C--N 1.29 -2.014 0 C-N-CA 124.89 1.276 . . . . 0.0 110.789 -175.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.59 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 25.6 mt -106.5 150.46 39.57 Favored Pre-proline 0 C--N 1.31 -1.128 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -57.62 152.05 50.92 Favored 'Trans proline' 0 CA--C 1.55 1.302 0 C-N-CA 122.669 2.246 . . . . 0.0 113.64 178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 70.04 28.07 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.252 1.421 . . . . 0.0 111.496 176.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.418 ' HB1' HG22 ' A' ' 36' ' ' VAL . . . 72.9 30.63 1.67 Allowed 'General case' 0 C--O 1.255 1.387 0 C-N-CA 124.023 0.929 . . . . 0.0 112.0 176.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.59 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 1.0 OUTLIER -91.98 150.91 20.75 Favored 'General case' 0 C--N 1.313 -1.003 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 171.814 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -135.47 142.44 45.53 Favored 'General case' 0 C--N 1.283 -2.315 0 O-C-N 121.993 -0.442 . . . . 0.0 109.917 177.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -93.93 103.53 15.63 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 19.0 t -113.31 148.13 16.44 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.11 -174.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 31' ' ' GLU . 37.4 tt0 -114.15 114.45 26.06 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.9 mt -61.33 164.14 5.82 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 122.814 0.446 . . . . 0.0 111.486 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.05 -20.35 6.3 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 124.613 1.165 . . . . 0.0 110.506 176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -85.66 -7.67 58.67 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.214 1.005 . . . . 0.0 111.675 -177.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.76 10.26 79.47 Favored Glycine 0 N--CA 1.465 0.6 0 C-N-CA 120.009 -1.091 . . . . 0.0 111.634 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -94.8 140.4 29.96 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 25' ' ' GLU . 4.4 pt-20 -95.72 149.13 21.82 Favored 'General case' 0 C--N 1.283 -2.318 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.699 HG22 ' HA ' ' A' ' 63' ' ' THR . 32.0 pt -139.0 150.55 23.3 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.15 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 -176.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 73.6 mt -103.55 123.12 46.33 Favored 'General case' 0 N--CA 1.414 -2.243 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 175.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.73 159.65 37.8 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.967 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.51 ' HD2' ' SD ' ' A' ' 21' ' ' MET . 48.0 t-80 -120.66 148.55 43.77 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG22 ' HB1' ' A' ' 20' ' ' ALA . 29.6 m -83.65 149.11 4.6 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 85.6 p -64.23 160.57 18.3 Favored 'General case' 0 C--O 1.255 1.344 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -58.63 -21.21 49.45 Favored Glycine 0 CA--C 1.525 0.707 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.953 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -77.56 -37.5 50.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 117.247 0.524 . . . . 0.0 110.61 -176.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.446 HG23 ' O ' ' A' ' 45' ' ' ILE . 70.5 mt -76.82 -30.06 18.21 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-O 121.375 0.607 . . . . 0.0 110.319 -179.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 33.1 ttt180 -69.39 -44.14 72.07 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.052 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 24.2 mmt -77.09 -44.99 28.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.771 1.026 . . . . 0.0 113.771 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.2 -176.51 5.95 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 113.751 1.019 . . . . 0.0 113.751 -171.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 47.6 p90 -87.7 -1.36 57.91 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.11 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.446 ' O ' HG23 ' A' ' 40' ' ' ILE . 26.6 pt -82.91 55.25 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 122.227 1.013 . . . . 0.0 109.698 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 44.4 mtp85 -83.63 151.45 25.3 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.157 -1.383 . . . . 0.0 111.233 -171.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.599 ' CG2' HG11 ' A' ' 13' ' ' VAL . 61.5 mt -91.12 132.41 35.71 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.716 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ASP . 10.4 mp -122.28 139.98 31.68 Favored Pre-proline 0 C--N 1.314 -0.956 0 C-N-CA 123.753 0.821 . . . . 0.0 110.632 177.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.429 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 88.4 Cg_exo -46.96 127.87 12.94 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 123.218 2.612 . . . . 0.0 112.112 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.92 -14.04 41.17 Favored Glycine 0 N--CA 1.439 -1.14 0 N-CA-C 111.393 -0.683 . . . . 0.0 111.393 -177.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.452 ' CG ' HH22 ' A' ' 70' ' ' ARG . 0.8 OUTLIER -84.43 159.24 20.83 Favored 'General case' 0 C--O 1.246 0.907 0 CA-C-O 120.85 0.357 . . . . 0.0 111.061 -179.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -109.56 129.22 55.59 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.1 m -133.88 160.13 42.1 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 O-C-N 121.616 -0.678 . . . . 0.0 112.441 -176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.4 m -99.61 130.48 45.84 Favored 'General case' 0 N--CA 1.435 -1.219 0 CA-C-N 115.261 -0.881 . . . . 0.0 108.981 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -124.36 132.83 70.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 122.382 0.273 . . . . 0.0 111.208 -176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -95.89 130.53 42.83 Favored 'General case' 0 CA--C 1.493 -1.222 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 8.2 ptp -139.98 149.87 43.78 Favored 'General case' 0 C--N 1.285 -2.229 0 CA-C-O 121.694 0.759 . . . . 0.0 112.936 -175.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 59' ' ' PRO . 1.9 p -77.16 135.13 66.68 Favored Pre-proline 0 N--CA 1.399 -2.978 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 58' ' ' SER . 29.2 Cg_exo -63.43 -13.47 36.4 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.018 2.479 . . . . 0.0 112.535 179.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -82.1 -17.11 47.66 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.102 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -117.56 -69.77 0.83 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.744 0.783 . . . . 0.0 109.601 -177.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.2 tp 61.44 8.41 2.18 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.134 1.774 . . . . 0.0 110.557 -175.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.699 ' HA ' HG22 ' A' ' 32' ' ' ILE . 14.5 t -126.89 5.8 6.61 Favored 'General case' 0 N--CA 1.423 -1.777 0 CA-C-O 122.327 1.06 . . . . 0.0 108.434 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.2 tpt180 -143.36 136.51 27.94 Favored 'General case' 0 N--CA 1.426 -1.657 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -168.38 -172.03 34.86 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 119.776 -1.202 . . . . 0.0 111.678 -178.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 25.1 ttp85 -138.02 137.33 37.76 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 47' ' ' ILE . 2.7 mp -70.32 127.8 32.73 Favored 'Isoleucine or valine' 0 C--O 1.255 1.383 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.387 177.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.5 p -104.07 -24.98 13.15 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.81 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -153.4 139.11 17.91 Favored 'General case' 0 N--CA 1.421 -1.919 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.18 -176.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 HH22 ' CG ' ' A' ' 51' ' ' ASP . 0.5 OUTLIER -102.8 106.79 17.46 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 174.708 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -77.1 147.75 36.45 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.04 0 CA-C-O 117.793 -1.098 . . . . 0.0 108.222 176.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.72 82.44 5.75 Favored 'General case' 0 N--CA 1.443 -0.775 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -162.55 9.1 0.06 Allowed 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 50.13 81.5 0.06 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 122.361 1.077 . . . . 0.0 110.197 -169.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -85.5 -14.24 46.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.051 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.6 t -105.68 147.46 11.32 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 49.0 mm -103.77 126.54 58.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.419 -175.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -102.77 116.48 32.65 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.639 -179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.485 HD12 ' SD ' ' A' ' 57' ' ' MET . 39.1 mt -127.65 162.52 26.33 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.933 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.84 153.09 31.07 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 105.239 -2.134 . . . . 0.0 105.239 177.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -166.44 167.21 39.35 Favored Glycine 0 N--CA 1.428 -1.856 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.936 -177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.1 m -114.82 126.73 55.15 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.348 0.594 . . . . 0.0 110.591 -175.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.559 ' HB ' HG22 ' A' ' 24' ' ' VAL . 6.2 p -89.52 129.12 41.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.049 0.452 . . . . 0.0 112.115 -178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.584 HD23 ' H ' ' A' ' 14' ' ' LEU . 1.4 pt? -106.32 -34.19 7.54 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' LYS . 5.9 m-20 -127.61 148.16 50.36 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.234 -174.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 p -100.91 132.39 46.34 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 123.081 0.552 . . . . 0.0 110.585 179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 31.0 mt -110.08 150.85 42.03 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.26 151.88 64.29 Favored 'Trans proline' 0 CA--C 1.554 1.513 0 C-N-CA 122.396 2.064 . . . . 0.0 113.763 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 t30 66.49 30.5 8.58 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 125.011 1.324 . . . . 0.0 112.573 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.53 27.89 1.32 Allowed 'General case' 0 C--O 1.25 1.101 0 C-N-CA 123.996 0.918 . . . . 0.0 112.343 175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.487 ' CB ' ' HB2' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -91.52 151.9 20.56 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 169.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -138.79 141.53 38.77 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 36.6 tttm -98.28 105.05 17.14 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 175.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.1 t -112.97 142.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.92 0 CA-C-N 114.071 -1.422 . . . . 0.0 108.41 -174.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.31 131.6 54.04 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 172.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD21 ' HE1' ' A' ' 57' ' ' MET . 85.8 mt -67.1 158.56 30.84 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.329 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.76 -13.9 47.91 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-O 122.189 0.995 . . . . 0.0 109.766 177.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -83.62 -7.69 59.45 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.808 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.38 10.23 74.4 Favored Glycine 0 C--O 1.221 -0.713 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.356 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -95.12 157.79 15.74 Favored 'General case' 0 N--CA 1.437 -1.119 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 2.2 pm0 -95.41 142.65 27.53 Favored 'General case' 0 C--N 1.277 -2.567 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 -178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' A' ' 63' ' ' THR . 29.8 pt -139.8 138.54 38.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 121.944 0.878 . . . . 0.0 109.659 173.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.7 mt -101.93 123.35 45.69 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 104.593 -2.373 . . . . 0.0 104.593 172.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -128.04 159.0 36.4 Favored 'General case' 0 C--N 1.274 -2.677 0 CA-C-N 115.727 -0.669 . . . . 0.0 112.099 -171.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 86.5 t60 -131.25 136.51 48.27 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.903 177.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -82.74 148.21 5.37 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 62.2 p -63.33 160.8 15.18 Favored 'General case' 0 C--O 1.252 1.23 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.714 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -55.12 -25.42 39.1 Favored Glycine 0 N--CA 1.436 -1.335 0 CA-C-N 115.259 -0.882 . . . . 0.0 112.981 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -74.28 -45.91 44.66 Favored 'General case' 0 C--O 1.201 -1.459 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.228 -178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 45' ' ' ILE . 43.5 mt -62.84 -40.89 90.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.468 -179.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -66.86 -48.59 68.35 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.334 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 17.3 mmt -76.72 -29.1 56.08 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.8 -3.01 58.44 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -175.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 61.44 20.84 11.53 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 124.383 1.073 . . . . 0.0 113.508 -179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.515 ' O ' HG23 ' A' ' 40' ' ' ILE . 17.7 pt -83.72 66.91 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 CA-C-O 123.101 1.429 . . . . 0.0 109.711 176.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 38.3 ptt180 -67.18 151.09 48.18 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.292 -171.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 HG22 HG11 ' A' ' 13' ' ' VAL . 27.9 mm -97.45 132.97 40.94 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 113.944 -1.48 . . . . 0.0 107.519 178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.409 HD12 ' HD2' ' A' ' 49' ' ' PRO . 30.8 tp -109.51 138.77 20.66 Favored Pre-proline 0 C--N 1.284 -2.252 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.409 ' HD2' HD12 ' A' ' 48' ' ' LEU . 34.1 Cg_exo -45.14 127.76 9.03 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.014 1.809 . . . . 0.0 111.052 171.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 108.17 -18.58 33.37 Favored Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 111.129 -0.788 . . . . 0.0 111.129 -173.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -74.7 153.55 38.82 Favored 'General case' 0 C--O 1.249 1.06 0 CA-C-O 121.605 0.717 . . . . 0.0 111.035 177.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -112.17 144.64 41.21 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.0 m -141.55 157.15 21.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.432 0.634 . . . . 0.0 112.675 -171.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 18.7 m -95.9 115.2 27.08 Favored 'General case' 0 C--O 1.259 1.564 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.456 ' CG2' ' HA3' ' A' ' 65' ' ' GLY . 12.1 p -112.98 127.02 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.11 -174.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.535 ' CD ' HH12 ' A' ' 66' ' ' ARG . 53.5 mt-10 -95.71 125.5 40.33 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.588 ' HE1' HD21 ' A' ' 26' ' ' LEU . 13.4 ptp -140.69 155.65 46.42 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -172.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.4 p -74.64 132.47 78.08 Favored Pre-proline 0 N--CA 1.407 -2.58 0 CA-C-N 114.785 -1.098 . . . . 0.0 109.723 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -65.33 -13.52 40.24 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 123.272 2.648 . . . . 0.0 112.582 -178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -86.4 -16.42 37.29 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.283 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -114.03 -69.4 0.86 Allowed 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 119.873 -0.731 . . . . 0.0 112.831 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 11.1 mp 59.11 20.8 8.74 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.368 -170.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.437 ' HA ' HG22 ' A' ' 32' ' ' ILE . 10.1 t -127.97 6.05 5.99 Favored 'General case' 0 CA--C 1.564 1.488 0 CA-C-O 122.8 1.286 . . . . 0.0 108.877 175.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -133.26 164.49 26.96 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.456 ' HA3' ' CG2' ' A' ' 55' ' ' VAL . . . 179.01 165.7 33.77 Favored Glycine 0 N--CA 1.432 -1.612 0 C-N-CA 118.798 -1.668 . . . . 0.0 113.379 172.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.547 ' NH1' HG23 ' A' ' 68' ' ' THR . 2.7 tmm_? -130.37 129.08 42.66 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.2 mp -95.95 126.51 48.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.547 HG23 ' NH1' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -107.13 -24.23 12.01 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.361 172.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -135.18 141.37 45.87 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 119.664 -0.815 . . . . 0.0 110.725 -176.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -120.36 143.13 48.57 Favored 'General case' 0 C--N 1.29 -1.988 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -62.53 124.74 21.76 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 122.249 1.023 . . . . 0.0 110.366 -178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.544 ' NZ ' ' HB3' ' A' ' 72' ' ' LYS . 0.3 OUTLIER . . . . . 0 C--N 1.283 -2.307 0 CA-C-N 112.666 -2.061 . . . . 0.0 106.754 -178.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.216 0 CA-C-O 121.013 0.435 . . . . 0.0 110.013 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.84 -65.93 0.69 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 177.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 3' ' ' LYS . 46.4 mtmt -162.81 -60.91 0.04 OUTLIER 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -122.83 78.36 1.53 Allowed 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.285 -175.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -76.54 -15.97 59.74 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.294 1.045 . . . . 0.0 109.609 178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 50.4 t -129.3 142.31 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 102.892 -3.003 . . . . 0.0 102.892 169.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 64.8 mt -120.01 120.94 64.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.169 -0.613 . . . . 0.0 110.009 -176.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 46.2 mt-10 -102.33 126.32 49.3 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-O 121.301 0.572 . . . . 0.0 109.896 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.07 162.25 25.73 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.846 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.454 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 37.1 mt-10 -107.2 138.49 43.3 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -140.43 172.92 23.32 Favored Glycine 0 N--CA 1.425 -2.045 0 C-N-CA 120.114 -1.041 . . . . 0.0 111.313 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.0 m -122.97 128.75 50.65 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 24' ' ' VAL . 1.5 p -86.24 132.66 31.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -175.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.7 mt -104.77 -39.68 6.24 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.998 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -128.08 153.88 46.32 Favored 'General case' 0 C--O 1.246 0.872 0 CA-C-O 121.25 0.548 . . . . 0.0 111.247 -172.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.9 p -100.68 121.39 41.55 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.679 176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' HB2' ' CB ' ' A' ' 21' ' ' MET . 23.0 mt -106.93 150.2 39.48 Favored Pre-proline 0 C--N 1.31 -1.132 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' O ' ' HE2' ' A' ' 21' ' ' MET . 18.4 Cg_endo -59.94 152.46 64.28 Favored 'Trans proline' 0 CA--C 1.549 1.267 0 C-N-CA 122.635 2.223 . . . . 0.0 113.769 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 71.47 21.05 4.65 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 125.11 1.364 . . . . 0.0 112.109 174.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' HB3' ' HE ' ' A' ' 41' ' ' ARG . . . 77.86 33.51 0.35 Allowed 'General case' 0 C--O 1.251 1.17 0 C-N-CA 124.881 1.272 . . . . 0.0 112.355 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.493 ' HE2' ' O ' ' A' ' 18' ' ' PRO . 2.8 mpp? -96.25 155.41 16.77 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -143.42 144.21 31.93 Favored 'General case' 0 C--N 1.287 -2.151 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.5 ' HZ1' ' HB2' ' A' ' 31' ' ' GLU . 57.1 tttp -93.61 109.97 21.59 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.989 0.899 . . . . 0.0 108.611 175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 20.4 t -111.7 140.14 32.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.722 0 CA-C-N 113.762 -1.563 . . . . 0.0 107.742 -176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.596 ' OE1' ' HA ' ' A' ' 31' ' ' GLU . 0.2 OUTLIER -113.3 134.05 54.8 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.6 mt -81.42 163.47 22.77 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.488 0.661 . . . . 0.0 112.408 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.82 -27.23 68.1 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 124.889 1.276 . . . . 0.0 111.449 178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -73.48 -7.05 50.19 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 124.868 1.267 . . . . 0.0 111.354 179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.57 10.69 76.2 Favored Glycine 0 CA--C 1.5 -0.845 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -85.29 140.55 30.74 Favored 'General case' 0 N--CA 1.426 -1.637 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 -177.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.596 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 1.4 pp20? -96.22 135.92 37.4 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.452 HG22 ' HA ' ' A' ' 63' ' ' THR . 37.6 pt -136.95 150.66 26.76 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-O 122.19 0.995 . . . . 0.0 111.466 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.3 mt -119.69 125.48 48.79 Favored 'General case' 0 C--N 1.282 -2.365 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 176.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.25 158.57 42.57 Favored 'General case' 0 C--N 1.285 -2.234 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.564 -173.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.418 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 68.9 t60 -118.15 138.93 51.96 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.6 m -83.29 146.98 6.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 C-N-CA 119.97 -0.692 . . . . 0.0 112.307 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 93.4 p -64.65 161.93 16.74 Favored 'General case' 0 C--O 1.25 1.119 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.514 177.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -54.31 -14.85 4.97 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-N 116.108 -0.497 . . . . 0.0 113.777 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -63.56 -42.93 98.31 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.417 HG21 HG12 ' A' ' 47' ' ' ILE . 67.4 mt -90.75 -20.93 6.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 114.933 -1.03 . . . . 0.0 111.665 -174.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.499 ' HE ' ' HB3' ' A' ' 20' ' ' ALA . 50.4 mtp180 -79.3 -48.39 14.19 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.475 -0.89 . . . . 0.0 108.876 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -76.7 -45.75 28.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 33.0 t-20 -88.89 162.78 15.94 Favored 'General case' 0 C--O 1.217 -0.606 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -78.09 8.31 5.0 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.9 pt -82.59 50.51 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.152 0 CA-C-O 121.392 0.615 . . . . 0.0 111.51 -178.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mpt_? -68.36 151.26 47.13 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.976 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.586 ' CG2' HG11 ' A' ' 13' ' ' VAL . 49.6 mm -84.27 132.84 30.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.951 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 33.6 tp -115.71 138.33 23.83 Favored Pre-proline 0 C--N 1.299 -1.594 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -47.54 130.52 18.27 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.022 1.815 . . . . 0.0 111.184 174.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 107.77 -18.48 34.56 Favored Glycine 0 N--CA 1.436 -1.336 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.492 -174.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -68.57 150.45 48.0 Favored 'General case' 0 C--O 1.253 1.261 0 CA-C-O 121.648 0.737 . . . . 0.0 111.871 176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 10' ' ' GLU . 65.7 tttt -106.42 127.85 53.6 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 175.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.4 m -130.88 161.35 41.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-O 120.731 0.3 . . . . 0.0 111.779 -176.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 9.0 m -101.82 125.33 48.47 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 8' ' ' GLU . 14.4 p -115.18 133.4 61.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-N 116.835 -0.166 . . . . 0.0 111.054 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -94.93 126.85 40.55 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 176.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 2.1 mtp -133.64 154.74 50.67 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.108 -0.637 . . . . 0.0 110.218 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.1 m -83.39 136.75 42.64 Favored Pre-proline 0 C--N 1.284 -2.278 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.927 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_exo -63.61 -14.99 46.01 Favored 'Trans proline' 0 N--CA 1.488 1.179 0 C-N-CA 122.855 2.37 . . . . 0.0 112.411 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -91.17 -5.07 55.51 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.213 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -124.95 -74.69 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.557 0.694 . . . . 0.0 109.923 -178.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 12.5 tp 59.28 24.29 12.78 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.628 1.571 . . . . 0.0 112.066 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.514 HG23 ' HG2' ' A' ' 64' ' ' ARG . 5.1 t -127.35 -21.43 3.87 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-O 121.886 0.85 . . . . 0.0 109.852 175.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.514 ' HG2' HG23 ' A' ' 63' ' ' THR . 14.3 mmt180 -126.04 141.14 52.08 Favored 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 125.796 1.638 . . . . 0.0 107.977 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -164.45 -169.7 28.38 Favored Glycine 0 C--O 1.246 0.878 0 C-N-CA 119.372 -1.394 . . . . 0.0 113.094 -177.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 46.6 ttp180 -130.82 147.14 52.44 Favored 'General case' 0 C--N 1.312 -1.03 0 C-N-CA 122.496 0.318 . . . . 0.0 110.22 178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 mp -81.76 120.87 34.14 Favored 'Isoleucine or valine' 0 C--O 1.258 1.545 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.585 176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.2 p -95.27 -25.14 16.46 Favored 'General case' 0 C--O 1.263 1.794 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.747 179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -157.88 148.19 20.54 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.087 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -120.89 138.56 54.03 Favored 'General case' 0 N--CA 1.429 -1.496 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 174.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -73.93 126.26 30.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.765 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.035 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 178.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 C--O 1.252 1.201 0 N-CA-C 110.595 -0.15 . . . . 0.0 110.595 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.39 -76.49 0.06 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.303 1.441 . . . . 0.0 112.108 176.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.513 ' HZ2' ' HB2' ' A' ' 3' ' ' LYS . 8.6 mtmp? -106.63 -44.13 4.55 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 176.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -83.88 64.53 8.14 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 113.725 -1.58 . . . . 0.0 113.427 -168.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -114.59 -22.17 9.9 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 166.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 57.4 t -131.49 144.38 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 102.493 -3.151 . . . . 0.0 102.493 171.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 42.3 mm -105.14 139.54 25.87 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 -178.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.99 116.34 32.6 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.58 HD12 ' SD ' ' A' ' 57' ' ' MET . 66.4 mt -123.42 161.43 24.79 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.168 0.509 . . . . 0.0 110.701 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.466 ' HB3' ' NZ ' ' A' ' 52' ' ' LYS . 23.9 mm-40 -108.54 146.58 33.03 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.278 179.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -156.05 172.45 33.97 Favored Glycine 0 N--CA 1.428 -1.855 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.977 177.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.1 m -129.71 127.0 39.57 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.517 ' HB ' HG22 ' A' ' 24' ' ' VAL . 3.1 p -89.39 130.13 39.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.78 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.583 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 87.6 mt -101.68 -35.06 9.23 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 120.56 -0.456 . . . . 0.0 112.206 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.85 157.44 46.85 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 120.234 -0.587 . . . . 0.0 110.934 -175.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.2 p -99.88 134.68 42.42 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.105 -176.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' MET . 52.0 mt -110.2 150.82 42.05 Favored Pre-proline 0 C--N 1.312 -1.049 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.88 153.92 63.56 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.178 1.918 . . . . 0.0 112.281 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 64.8 t30 74.15 40.9 0.42 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 124.134 0.974 . . . . 0.0 111.956 176.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 62.74 26.54 15.68 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.559 0.695 . . . . 0.0 111.397 175.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.428 ' HB3' ' HB2' ' A' ' 17' ' ' LEU . 4.7 tpt -107.44 156.38 19.01 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 105.772 -1.936 . . . . 0.0 105.772 178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -143.82 147.38 34.02 Favored 'General case' 0 C--N 1.266 -3.036 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -102.09 115.06 29.74 Favored 'General case' 0 N--CA 1.418 -2.043 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 175.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG22 ' HB ' ' A' ' 13' ' ' VAL . 22.4 t -112.99 149.21 15.51 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.451 0 CA-C-N 114.047 -1.433 . . . . 0.0 108.775 -173.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -105.73 130.89 53.64 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.55 163.48 25.36 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.42 175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -56.6 -22.76 36.08 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 122.087 0.946 . . . . 0.0 110.344 177.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.57 -7.45 58.51 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.893 -1.048 . . . . 0.0 110.945 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 86.74 10.7 72.3 Favored Glycine 0 C--O 1.216 -0.989 0 C-N-CA 120.042 -1.075 . . . . 0.0 112.079 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -90.71 154.99 19.15 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.446 ' H ' ' CD ' ' A' ' 31' ' ' GLU . 4.9 pm0 -94.53 136.4 34.88 Favored 'General case' 0 C--N 1.277 -2.585 0 C-N-CA 123.762 0.825 . . . . 0.0 108.819 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.6 pt -139.5 143.39 30.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.406 177.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' A' ' 64' ' ' ARG . 69.8 mt -102.17 123.48 46.1 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 175.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.04 153.84 48.85 Favored 'General case' 0 C--N 1.268 -2.964 0 C-N-CA 119.664 -0.814 . . . . 0.0 111.406 -173.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 20.5 t60 -117.34 138.2 51.94 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.2 m -83.24 147.78 5.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 CA-C-O 120.731 0.3 . . . . 0.0 110.849 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 95.0 p -63.69 160.47 16.94 Favored 'General case' 0 C--O 1.252 1.203 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.894 -176.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.62 -19.49 48.76 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.1 176.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -72.26 -41.8 66.32 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 55.7 mt -68.37 -42.12 83.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.458 178.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -61.78 -46.21 90.54 Favored 'General case' 0 CA--C 1.555 1.158 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.931 179.171 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.6 mmt -76.0 -32.2 59.3 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.88 -5.6 59.05 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 120.397 -0.521 . . . . 0.0 111.323 -179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 85.5 m-85 57.42 28.41 15.36 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.504 1.122 . . . . 0.0 112.738 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.3 pt -78.8 84.03 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-O 122.544 1.164 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 44' ' ' TYR . 97.4 mtt180 -68.64 129.9 41.28 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 113.131 -1.85 . . . . 0.0 111.848 -173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.15 130.7 39.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 175.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD12 ' HD2' ' A' ' 49' ' ' PRO . 27.4 tp -98.97 138.52 20.64 Favored Pre-proline 0 C--N 1.296 -1.726 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.583 ' HB3' ' O ' ' A' ' 14' ' ' LEU . 22.8 Cg_exo -44.39 125.46 5.94 Favored 'Trans proline' 0 C--N 1.359 1.087 0 C-N-CA 122.792 2.328 . . . . 0.0 111.689 173.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.76 -4.69 39.59 Favored Glycine 0 N--CA 1.431 -1.686 0 N-CA-C 111.502 -0.639 . . . . 0.0 111.502 -177.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -84.47 158.95 20.86 Favored 'General case' 0 C--O 1.252 1.216 0 CA-C-O 121.199 0.523 . . . . 0.0 111.019 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' NZ ' ' HB3' ' A' ' 10' ' ' GLU . 5.7 tmtt? -104.71 129.93 52.84 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 m -137.69 153.49 28.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 23.6 m -100.24 120.45 39.92 Favored 'General case' 0 C--O 1.284 2.869 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.724 177.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -113.28 127.86 70.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.66 -174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -96.08 129.85 43.26 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . 0.82 ' SD ' ' HA ' ' A' ' 62' ' ' LEU . 10.5 ptp -146.84 148.84 32.27 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.0 m -73.83 150.32 88.34 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.27 -13.96 26.96 Favored 'Trans proline' 0 CA--C 1.548 1.191 0 C-N-CA 122.548 2.165 . . . . 0.0 111.79 176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.8 t80 -93.61 -4.66 50.37 Favored 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.727 0.811 . . . . 0.0 109.952 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -102.82 -97.24 0.29 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.82 ' HA ' ' SD ' ' A' ' 57' ' ' MET . 9.5 mp 60.49 9.2 1.95 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.344 1.058 . . . . 0.0 113.064 -173.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 t -128.04 -16.22 4.62 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.362 -1.29 . . . . 0.0 109.119 173.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -132.59 152.39 51.64 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 175.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -162.81 -178.37 36.58 Favored Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.099 -1.048 . . . . 0.0 112.7 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 35' ' ' HIS . 7.6 tmm_? -135.15 128.36 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.9 mp -97.41 127.66 49.46 Favored 'Isoleucine or valine' 0 C--O 1.258 1.505 0 CA-C-O 121.138 0.494 . . . . 0.0 111.613 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.5 p -113.82 -23.31 9.72 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.08 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -135.69 142.46 45.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-O 121.031 0.443 . . . . 0.0 111.285 -173.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -110.14 138.44 46.51 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 171.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -104.5 123.75 48.05 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-O 120.953 0.406 . . . . 0.0 109.925 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.448 ' HD2' ' HA ' ' A' ' 72' ' ' LYS . 15.9 tptt . . . . . 0 N--CA 1.417 -2.085 0 CA-C-O 116.172 -1.871 . . . . 0.0 107.088 175.606 . . . . . . . . 1 1 . 1 stop_ save_